,TARGET USI,Gender,Race,Ethnicity,Age at Diagnosis in Days,First Event,Event Free Survival Time in Days,Vital Status,Overall Survival Time in Days,Year of Diagnosis,Year of Last Follow Up,Protocol,INSS Stage,MYCN status,Ploidy,Ploidy Value,Histology,Grade,MKI,Diagnostic Category,ICDO,ICDO Description,COG Risk Group,Percent Tumor,Percent Necrosis,Percent Tumor v/s Stroma,Sites of Disease Involvement,Site Relapse,Relapse Percent Tumor,Relapse Percent Necrosis,Relapse Percent Tumor v/s Stroma,Comment,data_type,updated_datetime,file_name,submitter_id,file_id,file_size,id,created_datetime,md5sum,data_format,access,state,data_category,type,experimental_strategy,project.project_id,entity_id,case_id,entity_submitter_id,entity_type
0,TARGET-30-PAIFXV,Female,White,Unknown,2004,Event,630.0,Dead,1114.0,1995,1998.0,"9047, 9340, 9341, 9342, P9462",Stage 4,Not Amplified,Hyperdiploid (DI>1),1.06,Unfavorable,Unknown,Unknown,Unknown,Unknown,ABDOMEN/PERITONEUM OR RETROPERITONEUM,High Risk,,,,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,d8d30bd7-608d-4cbd-ba31-3f1fa6fefacf.htseq.counts,test_version109_GeneExpressionCounts,cfa24f91-5cea-4a45-8a00-afbebaea462b,1272287,cfa24f91-5cea-4a45-8a00-afbebaea462b,2017-10-06T08:29:48.873012-05:00,d86ccd5f9ed8f123c25a600b66ed7f43,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,f040bca5-d68f-533e-befc-be9399eaa73a,4a47a989-5650-5366-9c83-4fa7e1deaa83,TARGET-30-PAIFXV-01A-01R,aliquot
1,TARGET-30-PAIPGU,Female,White,Unknown,898,Death,436.0,Dead,436.0,1998,1999.0,9047,Stage 4,Not Amplified,Hyperdiploid (DI>1),1.04,Unknown,Unknown,Unknown,Unknown,Unknown,ADRENAL GLAND,High Risk,90,10,95/5,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,4f13947f-1cf8-44d6-bdb6-13f9668dbcfd.htseq.counts,test_version46_GeneExpressionCounts,18e284a1-0fb0-4e90-bdf5-a6d2464e26af,1266903,18e284a1-0fb0-4e90-bdf5-a6d2464e26af,2017-10-06T08:25:15.152144-05:00,5e88e02d2221f6dc65abb314a115fc53,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,f02dbb19-bf67-53fd-a201-54d02322264c,68779778-b56c-5cb0-9eef-03945dddc402,TARGET-30-PAIPGU-01A-01R,aliquot
2,TARGET-30-PAISNS,Male,White,Unknown,1070,Event,410.0,Dead,421.0,1998,1999.0,"9047, P9462",Stage 4,Not Amplified,Diploid (DI=1),1.0,Unknown,Unknown,Unknown,Unknown,Unknown,ADRENAL GLAND,High Risk,80-90,5,,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,4aae239e-9b2e-4a89-af99-ae4f3cbe1fff.htseq.counts,test_version10_GeneExpressionCounts,e0ae7fad-cf09-4fbc-be8c-6f66ded89d31,1263281,e0ae7fad-cf09-4fbc-be8c-6f66ded89d31,2017-10-06T08:22:37.905981-05:00,d8ca804502931daa3eed89a0e702dc9f,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,02e457e4-408a-50ca-90f0-e7cab928aa8d,2f3d43b1-2c71-51ad-a49e-a24c2b933f9e,TARGET-30-PAISNS-01A-01R,aliquot
3,TARGET-30-PAITCI,Male,White,Unknown,728,Event,232.0,Dead,324.0,1998,1999.0,"9047, 9082",Stage 4,Not Amplified,Hyperdiploid (DI>1),1.92,Favorable,Differentiating,Low,Neuroblastoma,Unknown,ADRENAL GLAND,High Risk,90,10,90/10,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,1eb90879-2cb0-4cc2-ae58-eefacd1715d0.htseq.counts,test_version75_GeneExpressionCounts,1888e5bd-fd6b-48cb-a59e-46a6e4518d11,1269445,1888e5bd-fd6b-48cb-a59e-46a6e4518d11,2017-10-06T08:27:34.954478-05:00,bcfeea5d06baf1f4bb126a8a62cb2ef1,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,bb71de8a-eb6c-50f9-8d9d-cf096bdd7df6,050f88fb-d776-52b1-8c33-d646d7c1e8ab,TARGET-30-PAITCI-01A-01R,aliquot
4,TARGET-30-PAIVHE,Male,White,Not Hispanic or Latino,1123,Event,672.0,Dead,1605.0,1999,2003.0,"9047, P9462, ANBL0321",Stage 4,Not Amplified,Hyperdiploid (DI>1),1.06,Unfavorable,Undifferentiated or Poorly Differentiated,Low,Neuroblastoma,C74.9,"Adrenal gland, NOS  Suprarenal gland  Adrenal, NOS",High Risk,90,10,70/30,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,f7541bf7-73bc-4163-af01-3fea29027a16.htseq.counts,test_version44_GeneExpressionCounts,a0f85380-dc8e-4424-985f-36c5d6fb861c,1271260,a0f85380-dc8e-4424-985f-36c5d6fb861c,2017-10-06T08:24:52.252607-05:00,6e63c261ad1362cbb12f2acd2f501aa8,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,26d3cbe3-e960-5ea5-9002-fe3d15a66712,6d07ecd4-e96c-51ff-8a00-952e3c785871,TARGET-30-PAIVHE-01A-01R,aliquot
5,TARGET-30-PAKYZS,Male,White,Not Hispanic or Latino,659,Progression,238.0,Alive,3587.0,2001,2011.0,ANBL00B1,Stage 4,Not Amplified,Hyperdiploid (DI>1),1.9,Unknown,Unknown,Unknown,Unknown,C74.1,Medulla of adrenal gland,High Risk,,,,,Bone Marrow,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,d12b7288-10b2-41fc-b5c0-b6227d5b92af.htseq.counts,test_version140_GeneExpressionCounts,18ab45e5-0746-4e69-b21c-32cddb1c27b5,1270276,18ab45e5-0746-4e69-b21c-32cddb1c27b5,2017-10-06T08:32:30.320255-05:00,c498fe6f1c8242051d32b9d1d17ac72c,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,6a2f12bf-2b24-5f53-bd11-836eb2824e39,ec543f8e-ac8a-5f2b-8260-78656d21c13c,TARGET-30-PAKYZS-01A-01R,aliquot
6,TARGET-30-PAKZRH,Male,White,Hispanic or Latino,21,Censored,3341.0,Alive,3341.0,2001,2010.0,"B947, ANBL00B1, A3961",Stage 4s,Not Amplified,Diploid (DI=1),1.0,Favorable,Undifferentiated or Poorly Differentiated,Low,Unknown,C74.1,Bilateral adrenal,Intermediate Risk,,,,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,0828a945-a123-4166-b93e-2071bd743c71.htseq.counts,test_version156_GeneExpressionCounts,438e8278-e836-44bd-8225-e90053838f6b,1268790,438e8278-e836-44bd-8225-e90053838f6b,2017-10-06T08:33:38.856860-05:00,ec7706d18b444470e946bf8a226056aa,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,e386e5bd-a715-5bcd-8a09-2dae49668f6b,92096e88-b265-595b-a6a2-f09fdafcffed,TARGET-30-PAKZRH-01A-01R,aliquot
7,TARGET-30-PALBFW,Male,White,Not Hispanic or Latino,804,Relapse,611.0,Dead,1073.0,2001,2004.0,"ANBL00B1, A3973, ANBL0032",Stage 4,Not Amplified,Diploid (DI=1),1.0,Unfavorable,Undifferentiated or Poorly Differentiated,Low,Neuroblastoma,C74.1,Medulla of adrenal gland,High Risk,85,15,80/20,,"Bone Marrow; Other, specify: CT Scan May 2/03- Soft- tissue density mass in the anterior epidural space from L3 to L5 and the larger mass in the central canal at S3-S4 consistent with metastatic disease.",,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,f9c9806d-716e-405d-babf-1f2142b449df.htseq.counts,test_version146_GeneExpressionCounts,ea83302f-0446-4a7f-bf65-dc86265f6e74,1271248,ea83302f-0446-4a7f-bf65-dc86265f6e74,2017-10-06T08:32:53.477865-05:00,30ae7cbb74f9250a1cf9911e405e29db,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,54438829-40b9-535d-9eb8-70df3f08d7e2,255cd479-b023-5cad-baf7-daceaf247725,TARGET-30-PALBFW-01A-01R,aliquot
8,TARGET-30-PALCBW,Female,White,Not Hispanic or Latino,679,Censored,4565.0,Alive,4565.0,2001,2014.0,ANBL00B1,Stage 4,Not Amplified,Diploid (DI=1),1.0,Favorable,Differentiating,Low,Neuroblastoma,C74.1,Medulla of adrenal gland,High Risk,90,1,,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,8ed55a74-56b7-486a-86cb-87aecd0a84bf.htseq.counts,test_version116_GeneExpressionCounts,444f69bd-417c-4b36-b1e7-8ee33ce9ae42,1270417,444f69bd-417c-4b36-b1e7-8ee33ce9ae42,2017-10-06T08:30:35.588194-05:00,35e53ebf32e9803f856952a683732ca7,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,ef251c71-43c1-5a70-8e8e-ee6a63d878e7,41a1b1f2-f54e-5853-bbf5-83487bbb762d,TARGET-30-PALCBW-01A-01R,aliquot
9,TARGET-30-PALETP,Female,White,Not Hispanic or Latino,1466,Death,251.0,Dead,251.0,2001,2002.0,"ANBL00B1, A3973",Stage 4,Not Amplified,Diploid (DI=1),1.0,Unfavorable,Undifferentiated or Poorly Differentiated,Intermediate,Neuroblastoma,C38.2,Posterior mediastinum,High Risk,,,,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,3bd0d901-5f08-48c3-91b6-27acd103e6b6.htseq.counts,test_version14_GeneExpressionCounts,59e4c575-324d-4697-9609-2619e8927972,1264101,59e4c575-324d-4697-9609-2619e8927972,2017-10-06T08:22:37.905981-05:00,3ed388c61e6507735e49480ca695f26f,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,82894ca3-3c31-5b14-a626-076a6d408002,657566a4-d809-53af-9acd-d44fa6171b48,TARGET-30-PALETP-01A-01R,aliquot
10,TARGET-30-PALEVG,Male,White,Not Hispanic or Latino,666,Censored,4948.0,Alive,4948.0,2001,2015.0,"ANBL00B1, A3973, ANBL0032, ALTE05N1, ALTE03N1",Stage 4,Amplified,Hyperdiploid (DI>1),1.3,Unfavorable,Undifferentiated or Poorly Differentiated,Intermediate,Neuroblastoma,C74.1,Medulla of adrenal gland,High Risk,,,,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,17ff18b9-9c97-45d4-9b8f-63f00f9afe6b.htseq.counts,test_version66_GeneExpressionCounts,0881241f-af6f-4fe3-919c-0c8809e9c467,1270452,0881241f-af6f-4fe3-919c-0c8809e9c467,2017-10-06T08:26:46.721146-05:00,206452d3a7b7a72819ddc6b63ee3f0ea,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,1d5da160-113f-56ce-baa5-667a7e1a3e2c,3e23acca-250c-59fd-a8aa-a3d7e1fa9e55,TARGET-30-PALEVG-01A-01R,aliquot
11,TARGET-30-PALIIN,Male,White,Not Hispanic or Latino,1279,Relapse,684.0,Dead,1395.0,2002,2005.0,"ANBL00B1, A3973",Stage 4,Not Amplified,Hyperdiploid (DI>1),1.2,Unfavorable,Undifferentiated or Poorly Differentiated,High,Neuroblastoma,C80.9,Unknown primary site,High Risk,95,5,90/10,,"Other, specify: Lymph nodes-neck, mediastinal and paraspinal",,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,7e145f1d-1807-4615-95b5-2684ccbcb348.htseq.counts,test_version83_GeneExpressionCounts,87cb2067-679b-4cff-a264-d5e108ccb1b0,1277677,87cb2067-679b-4cff-a264-d5e108ccb1b0,2017-10-06T08:27:57.735394-05:00,fda76a3895021d8664e7fadd79605d70,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,cb636410-7681-59f7-8b6a-bfc37cf52da4,4f7aaa75-432c-5e97-be0a-8f7c1521eaf0,TARGET-30-PALIIN-01A-01R,aliquot
12,TARGET-30-PALKUC,Female,Black or African American,Not Hispanic or Latino,823,Censored,4399.0,Alive,4399.0,2002,2014.0,ANBL00B1,Stage 4,Amplified,Diploid (DI=1),1.0,Unfavorable,Undifferentiated or Poorly Differentiated,High,Neuroblastoma,C74.1,Medulla of adrenal gland,High Risk,100,0,,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,0851d235-5d5f-48d2-9e39-3e8a8863b5bb.htseq.counts,test_version89_GeneExpressionCounts,bcbb93da-dddf-4819-ae96-0ffbd9857744,1263514,bcbb93da-dddf-4819-ae96-0ffbd9857744,2017-10-06T08:28:17.762914-05:00,4b32342dd3f757e5c4a3cf9e7889ae9d,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,16b39c33-4e29-5d22-b17f-1b089d500c79,9bc8ff9e-2f36-5094-ac12-b1bf81b53c15,TARGET-30-PALKUC-01A-01R,aliquot
13,TARGET-30-PALNVP,Female,White,Not Hispanic or Latino,1155,Censored,4665.0,Alive,4665.0,2002,2015.0,"ANBL00B1, A3973",Stage 4,Not Amplified,Hyperdiploid (DI>1),1.44,Unfavorable,Undifferentiated or Poorly Differentiated,Low,Neuroblastoma,C76.3,"Pelvis, NOS  Buttock, NOS  Groin, NOS  Ischiorectal fossa  Pelvic wall, NOS  Perineum, NOS  Rectovaginal septum  Rectovesical septum  Gluteal region, NOS  Inguinal region, NOS  Perirectal region, NOS  Presacral region, NOS  Sacrococcygeal region, NOS",High Risk,90,5,,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,0a57b5c6-4a57-49b0-b20c-6252d39f002a.htseq.counts,test_version137_GeneExpressionCounts,5af584ef-5dc4-42dd-b136-eff03f9e6a8c,1262447,5af584ef-5dc4-42dd-b136-eff03f9e6a8c,2017-10-06T08:32:06.875552-05:00,beb367ce36b50a4950cbec926ecab8c7,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,c3a7c126-3954-5273-bdc1-025bae9d608b,328808f2-2db0-5b37-8c43-9878b29c4f0f,TARGET-30-PALNVP-01A-01R,aliquot
14,TARGET-30-PALTEG,Male,White,Not Hispanic or Latino,1367,Relapse,523.0,Dead,551.0,2002,2004.0,ANBL00B1,Stage 4,Not Amplified,Hyperdiploid (DI>1),1.96,Unfavorable,Undifferentiated or Poorly Differentiated,Intermediate,Neuroblastoma,C76.2,"Abdomen, NOS  Abdominal wall, NOS  Intra-abdominal site, NOS",High Risk,,,,,Other Metastatic Sites,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,753eb36e-4e92-49ed-b563-5e0b8635b30c.htseq.counts,test_version160_GeneExpressionCounts,52dd0c75-8148-4684-86e2-9e13ff3702e8,1272098,52dd0c75-8148-4684-86e2-9e13ff3702e8,2017-10-06T08:33:48.934541-05:00,39f8869216d65b6db82ee59cf8207e86,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,38e8a320-90c4-5fdf-b5b7-4930cddd949f,ce8a8545-1b1b-5366-8d57-39d63b0388b6,TARGET-30-PALTEG-01A-01R,aliquot
15,TARGET-30-PALUYS,Female,White,Not Hispanic or Latino,1214,Relapse,693.0,Dead,1284.0,2002,2006.0,ANBL00B1,Stage 4,Not Amplified,Hyperdiploid (DI>1),1.14,Unfavorable,Undifferentiated or Poorly Differentiated,High,Neuroblastoma,C76.2,"Abdomen, NOS  Abdominal wall, NOS  Intra-abdominal site, NOS",High Risk,90,10,40/60,,Other Metastatic Sites,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,0b716d72-8978-47e3-9598-9bad87a71c29.htseq.counts,test_version38_GeneExpressionCounts,d5c0f504-8bbe-4e56-87f7-606f94340353,1270670,d5c0f504-8bbe-4e56-87f7-606f94340353,2017-10-06T08:24:28.919403-05:00,c867e3a72f49de1949a43c8ebcf1016c,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,30cf3420-66a3-51b3-9bd7-7e2639fc9b87,3bb9d365-5eb8-530f-9a8b-e00e1ea4a24e,TARGET-30-PALUYS-01A-01R,aliquot
16,TARGET-30-PALVKK,Female,White,Not Hispanic or Latino,1810,Event,217.0,Dead,1033.0,2002,2005.0,"ANBL00B1, A3973, AADM01P1",Stage 4,Not Amplified,Diploid (DI=1),1.0,Unfavorable,Undifferentiated or Poorly Differentiated,Low,"Ganglioneuroblastoma, nodular",C74.1,Medulla of adrenal gland,High Risk,80,0-20,95/5,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,20cfdbe0-d8be-4a00-aab9-d3011912a8dc.htseq.counts,test_version37_GeneExpressionCounts,4af4e64a-78f7-430a-a62e-08728ad76ffa,1274221,4af4e64a-78f7-430a-a62e-08728ad76ffa,2017-10-06T08:24:28.919403-05:00,e755e95a725b901f9b96af36f29775b5,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,921f0ee9-b621-57c0-bac0-5efd320ba080,2b9c92d3-e4d7-5539-a08b-cf68a21143f7,TARGET-30-PALVKK-01A-01R,aliquot
17,TARGET-30-PALWVJ,Male,Black or African American,Not Hispanic or Latino,1544,Relapse,417.0,Dead,803.0,2002,2004.0,ANBL00B1,Stage 4,Not Amplified,Hyperdiploid (DI>1),1.88,Unfavorable,Undifferentiated or Poorly Differentiated,Intermediate,Neuroblastoma,C74.1,Medulla of adrenal gland,High Risk,40,60,90/10,,Bone Marrow,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,e2471e44-3677-40cd-9768-a71301fa2e53.htseq.counts,test_version64_GeneExpressionCounts,a9599472-8f67-4234-84df-9279b2c2e4d3,1272453,a9599472-8f67-4234-84df-9279b2c2e4d3,2017-10-06T08:26:21.324309-05:00,a2fe001332158c2c277dbf30929bf43b,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,93e42057-8699-539d-9c05-3ebc6c9dbc87,b4f7373c-f32c-5b6b-bbde-add5f43a0adf,TARGET-30-PALWVJ-01A-01R,aliquot
18,TARGET-30-PALXTB,Male,White,Not Hispanic or Latino,635,Censored,4621.0,Alive,4621.0,2002,2015.0,"ANBL00B1, A3973, ALTE05N1",Stage 4,Not Amplified,Hyperdiploid (DI>1),1.92,Unfavorable,Undifferentiated or Poorly Differentiated,Low,Neuroblastoma,C74.1,Medulla of adrenal gland,High Risk,80-90,10,,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,5f98aeeb-518c-4546-a252-ba7049de61bf.htseq.counts,test_version32_GeneExpressionCounts,43ec9f6b-fc9d-4d37-a6be-4bee07ff75b8,1262877,43ec9f6b-fc9d-4d37-a6be-4bee07ff75b8,2017-10-06T08:24:05.575877-05:00,62501deeb46f10b0e749f98a8943e0d7,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,ee16ead7-df94-5ea2-b298-a7003c5a3612,dfc6d149-0018-557e-98fc-90def8cd8086,TARGET-30-PALXTB-01A-01R,aliquot
19,TARGET-30-PALZZV,Female,Black or African American,Not Hispanic or Latino,699,Event,1494.0,Alive,1934.0,2002,2008.0,ANBL00B1,Stage 4,Amplified,Hyperdiploid (DI>1),1.79,Unfavorable,Undifferentiated or Poorly Differentiated,Intermediate,Neuroblastoma,C74.1,Medulla of adrenal gland,High Risk,95,5,90/10,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,85af4f77-be45-4871-bdfb-f5b60223ed2f.htseq.counts,test_version8_GeneExpressionCounts,3868b38a-cca1-46d4-b880-9285c67a40a4,1268313,3868b38a-cca1-46d4-b880-9285c67a40a4,2017-10-06T08:22:14.253049-05:00,d4f8f6628538953888e336f9df6b066b,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,1501ff31-ade6-532e-9720-32704cf36512,b1f28caa-9cf7-5583-805b-6f8108dc8eb8,TARGET-30-PALZZV-01A-01R,aliquot
20,TARGET-30-PAMEZH,Female,Black or African American,Not Hispanic or Latino,746,Death,330.0,Dead,330.0,2003,2004.0,ANBL00B1,Stage 4,Amplified,Hyperdiploid (DI>1),1.82,Unknown,Unknown,Unknown,Unknown,C48.0,Retroperitoneum  Periadrenal tissue  Perinephric tissue  Peripancreatic tissue  Perirenal tissue  Retrocecal tissue  Retroperitoneal tissue,High Risk,85,15,75/25,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,d7fefb38-3c90-4b7d-9d9e-85e1ca18eb3f.htseq.counts,test_version58_GeneExpressionCounts,a229c849-c790-4b41-a4fb-7ec86c309411,1272473,a229c849-c790-4b41-a4fb-7ec86c309411,2017-10-06T08:25:57.903017-05:00,9e9408b37f0a4ed43c8a1cd40939a9ea,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,1a90d50f-d780-5440-9ade-79b58dbb8c85,ea4ccfb1-7f21-5ddf-aae2-576ed5f26955,TARGET-30-PAMEZH-01A-01R,aliquot
21,TARGET-30-PAMMXF,Male,Unknown,Not Hispanic or Latino,1661,Relapse,140.0,Dead,197.0,2003,2004.0,ANBL00B1,Stage 4,Amplified,Hyperdiploid (DI>1),1.07,Unfavorable,Undifferentiated or Poorly Differentiated,Low,Neuroblastoma,C74.9,"Adrenal gland, NOS  Suprarenal gland  Adrenal, NOS",High Risk,75,25,90/10,,"Other, specify: Patient relapsed, diagnosed with Meninges.",,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,4116d3d5-c025-4e2f-a675-cfb71c8351ed.htseq.counts,test_version101_GeneExpressionCounts,6c7aeb93-94e0-433d-b108-e3b7e3897613,1264976,6c7aeb93-94e0-433d-b108-e3b7e3897613,2017-10-06T08:29:25.488029-05:00,eae50c9bc6e31554dcb278ea4aecffcc,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,4b736240-fd8d-5402-99fa-0e0dcbe1a5ec,e2b09398-86a8-5708-9342-3d79601ab52c,TARGET-30-PAMMXF-01A-01R,aliquot
22,TARGET-30-PAMNLH,Female,White,Not Hispanic or Latino,1531,Relapse,361.0,Dead,837.0,2003,2005.0,"ANBL00B1, A3973",Stage 4,Not Amplified,Hyperdiploid (DI>1),1.81,Unfavorable,Undifferentiated or Poorly Differentiated,Intermediate,"Ganglioneuroblastoma, nodular",C64.9,"Kidney, NOS  Renal, NOS  Kidney parenchyma",High Risk,85,35,,,Bone; Bone Marrow,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,d40bb6fb-fb99-4907-8d19-f0469f10bd10.htseq.counts,test_version2_GeneExpressionCounts,0d0638dc-3c4a-4218-83e2-34347e69e71a,1262120,0d0638dc-3c4a-4218-83e2-34347e69e71a,2017-10-06T08:21:49.750654-05:00,63eb9768fd94a6578ba0702082d91d15,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,b72e1eb4-a0d4-5ccf-975c-356f8e61acb5,7f61d2a1-703b-5e17-af68-16d2565f7556,TARGET-30-PAMNLH-01A-01R,aliquot
23,TARGET-30-PAMVRA,Female,White,Not Hispanic or Latino,1554,Death,2433.0,Dead,2433.0,2004,2010.0,"ANBL00B1, A3973, AADM01P1",Stage 4,Not Amplified,Hyperdiploid (DI>1),1.17,Unfavorable,Differentiating,Low,"Ganglioneuroblastoma, nodular",C74.9,"Adrenal gland, NOS  Suprarenal gland  Adrenal, NOS",High Risk,75-85,10,,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,8f70446e-c591-4ac1-bacb-64f78acf056f.htseq.counts,test_version28_GeneExpressionCounts,b3470ead-f401-4c8c-a8cd-6fa0252931cb,1266590,b3470ead-f401-4c8c-a8cd-6fa0252931cb,2017-10-06T08:23:42.670826-05:00,815c9d4c36bfe99ba16a35fcc9f2bb0b,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,9d5280f2-2cff-5604-95d7-d81a27ced6f1,b6c98e7c-1f25-5c9d-bece-d6fa15dd0248,TARGET-30-PAMVRA-01A-01R,aliquot
24,TARGET-30-PAMYCE,Female,White,Not Hispanic or Latino,1059,Relapse,392.0,Dead,995.0,2004,2006.0,"ANBL00B1, A3973, ANBL0032",Stage 4,Not Amplified,Diploid (DI=1),1.0,Unfavorable,Undifferentiated or Poorly Differentiated,Intermediate,Neuroblastoma,C74.9,"Adrenal gland, NOS  Suprarenal gland  Adrenal, NOS",High Risk,,,,,"Bone Marrow; Other, specify: Thorax including supraclavicular neck and mediastinum.",,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,78ff9515-5ac4-49f0-ad4c-ec169e644b9f.htseq.counts,test_version22_GeneExpressionCounts,e8adda1d-86f5-45d1-bd7e-e9d1f1ce3075,1266894,e8adda1d-86f5-45d1-bd7e-e9d1f1ce3075,2017-10-06T08:23:20.625172-05:00,394d44a5fe03b3b04626b8e1bc75c0ef,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,b6875f23-aa45-522b-b855-50ea4f4da91b,252c54ce-af58-5e0f-bd39-987b463e055e,TARGET-30-PAMYCE-01A-01R,aliquot
25,TARGET-30-PAMZGT,Male,White,Not Hispanic or Latino,602,Relapse,603.0,Alive,3823.0,2004,2014.0,"ANBL00B1, A3973",Stage 4,Amplified,Diploid (DI=1),1.0,Unknown,Unknown,Unknown,Neuroblastoma,C74.9,"Adrenal gland, NOS  Suprarenal gland  Adrenal, NOS",High Risk,,,,,"Other, specify: Cranial Fossa into Epidural Space",,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,2961321f-a06c-4ead-9bfd-b27d99e4ef08.htseq.counts,test_version119_GeneExpressionCounts,7595d58e-f4ee-4fbb-a8d3-ebdc6c00ffa1,1270757,7595d58e-f4ee-4fbb-a8d3-ebdc6c00ffa1,2017-10-06T08:30:35.588194-05:00,4555dc22ca4bc44cb096e500b64da31b,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,d3c65d5f-bfa3-53f9-9c34-21f0922cc6d6,eb4fa400-3697-5cf3-97a0-de06602eacd2,TARGET-30-PAMZGT-01A-01R,aliquot
26,TARGET-30-PAMZMG,Female,White,Not Hispanic or Latino,614,Relapse,533.0,Dead,763.0,2004,2006.0,"ANBL00B1, A3973",Stage 4,Amplified,Diploid (DI=1),1.0,Unfavorable,Undifferentiated or Poorly Differentiated,Intermediate,Neuroblastoma,C74.9,"Adrenal gland, NOS  Suprarenal gland  Adrenal, NOS",High Risk,,,,,Primary Site; Bone Marrow,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,a3bf1ee6-d71c-43ee-b775-6d28176bb8a9.htseq.counts,test_version126_GeneExpressionCounts,7c631538-8e1e-4319-af4e-cca68b235216,1263972,7c631538-8e1e-4319-af4e-cca68b235216,2017-10-06T08:31:18.033493-05:00,1a9d5ada31cc3c1d89a2003a7279d6a9,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,57596c78-3252-567c-b293-6cf3897e487e,5d670e22-ebb7-538b-a3f2-a89d912a22f9,TARGET-30-PAMZMG-01A-01R,aliquot
27,TARGET-30-PANBJH,Female,Black or African American,Not Hispanic or Latino,1030,Progression,168.0,Dead,920.0,2004,2006.0,"ANBL00B1, A3973, ANBL0322, ADVL0524",Stage 4,Not Amplified,Diploid (DI=1),1.0,Unfavorable,Undifferentiated or Poorly Differentiated,Intermediate,Neuroblastoma,C74.9,"Adrenal gland, NOS  Suprarenal gland  Adrenal, NOS",High Risk,,,,,Liver,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,230d1eae-b3b6-4db5-9fc0-7446ee92b717.htseq.counts,test_version80_GeneExpressionCounts,320e8c00-5bdb-44f6-a6a0-aedaf7923f46,1270517,320e8c00-5bdb-44f6-a6a0-aedaf7923f46,2017-10-06T08:27:57.735394-05:00,52b94e99c904a5e033ecf4c73500038a,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,9bdce9cd-4adb-5e7d-87fd-c09bff2b0e60,f70a24b1-aa49-5a60-b8e3-23e2768b3a41,TARGET-30-PANBJH-01A-01R,aliquot
28,TARGET-30-PANBMJ,Male,White,Not Hispanic or Latino,993,Relapse,577.0,Dead,3776.0,2004,2014.0,"ANBL00B1, P9641, A3973, ANBL0032, ALTE05N1, ADVL0813, ADVL0921",Stage 4,Not Amplified,Diploid (DI=1),1.0,Unfavorable,Undifferentiated or Poorly Differentiated,Low,"Ganglioneuroblastoma, nodular",C47.6,"Peripheral nerves and Autonomic nervous system of trunk, NOS  Peripheral nerves and Autonomic nervous system of (see list under C47):  . Back  . Flank  . Trunk  Lumbar nerve",High Risk,,,,,Primary Site,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,bfa13bce-0369-4315-8c94-903b898dbcaf.htseq.counts,test_version111_GeneExpressionCounts,1b76d0b5-21ba-47fb-a9f5-6f5179e3d2af,1275034,1b76d0b5-21ba-47fb-a9f5-6f5179e3d2af,2017-10-06T08:30:12.040966-05:00,65e2a33da17c132f7a751cc1c4f37dd8,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,532c9568-eb38-5b92-bba7-f08e2ca3b04e,fdfb389d-eb9a-5014-b391-9cd5f908720d,TARGET-30-PANBMJ-01A-01R,aliquot
29,TARGET-30-PANBSP,Female,White,Not Hispanic or Latino,1064,Relapse,470.0,Dead,659.0,2004,2006.0,"ANBL00B1, A3973",Stage 4,Not Amplified,Diploid (DI=1),1.0,Unfavorable,Undifferentiated or Poorly Differentiated,Low,Neuroblastoma,C64.9,"Kidney, NOS  Renal, NOS  Kidney parenchyma",High Risk,,,,,Bone,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,4638324b-b8e5-4545-8b7b-e8d7d7fdd138.htseq.counts,test_version16_GeneExpressionCounts,354e436f-3ded-4b2e-abc3-d85d7801d45e,1269745,354e436f-3ded-4b2e-abc3-d85d7801d45e,2017-10-06T08:23:00.878915-05:00,e674cc3b442a7bb5ac5edc8873f337d6,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,b3054bf3-4d49-53a1-a77c-f22965f9d4fb,e88037ef-beb8-5874-a175-ae5fa9bf8ebb,TARGET-30-PANBSP-01A-01R,aliquot
30,TARGET-30-PANGXK,Male,White,Not Hispanic or Latino,1266,Event,1855.0,Alive,3792.0,2004,2015.0,"ANBL02P1, ANBL00B1, ALTE03N1",Stage 4,Not Amplified,Diploid (DI=1),1.0,Unfavorable,Undifferentiated or Poorly Differentiated,Low,"Ganglioneuroblastoma, nodular",C47.3,Peripheral nerves and Autonomic nervous system of thorax  Peripheral nerves and Autonomic nervous system of (see list under C47):  . Axilla  . Chest  . chest wall  . thoracic wall  . infraclavicular region  . scapular region  Intercostal nerve,High Risk,95,5,95/5,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,43aeaf6a-3f84-41d2-9cd7-a6ead15aa241.htseq.counts,test_version56_GeneExpressionCounts,85665189-ad34-4fb2-9739-6afaa1c7292f,1267462,85665189-ad34-4fb2-9739-6afaa1c7292f,2017-10-06T08:25:57.903017-05:00,1f4c6444a8856dfdd98903c718743969,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,a6862aee-7667-54f7-8a5c-3a9537789af2,9da8ea16-845b-5cce-bf31-ec0a82ebc871,TARGET-30-PANGXK-01A-01R,aliquot
31,TARGET-30-PANJLH,Male,White,Not Hispanic or Latino,1010,Death,500.0,Dead,500.0,2004,2006.0,"ANBL00B1, A3973",Stage 4,Amplified,Diploid (DI=1),1.0,Unfavorable,Undifferentiated or Poorly Differentiated,Intermediate,Neuroblastoma,C76.2,"Abdomen, NOS  Abdominal wall, NOS  Intra-abdominal site, NOS",High Risk,,,,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,32616b41-5681-4f62-ac75-b40f935c9c7b.htseq.counts,test_version76_GeneExpressionCounts,c53ea4b1-9b4c-4389-a396-62cb3de213c8,1271338,c53ea4b1-9b4c-4389-a396-62cb3de213c8,2017-10-06T08:27:34.954478-05:00,283a78d74adb6bfe514a92fce97f9e20,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,5e5822b8-4bc0-526a-81b1-13766a7e89e9,d14fb175-07c7-5d4f-8e8f-76e7d9e06f7c,TARGET-30-PANJLH-01A-01R,aliquot
32,TARGET-30-PANLET,Female,Unknown,Unknown,1973,Relapse,830.0,Dead,1212.0,2005,2008.0,"ANBL00B1, ANBL0421",Stage 4,Not Amplified,Diploid (DI=1),1.0,Unfavorable,Unknown,Unknown,"Ganglioneuroblastoma, nodular",C74.9,"Adrenal gland, NOS  Suprarenal gland  Adrenal, NOS",High Risk,,,,,Bone; Bone Marrow,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,9b93ed0a-1316-4dd4-bfd8-b6807927a7ad.htseq.counts,test_version154_GeneExpressionCounts,28e5f49a-24a8-422c-a905-907f764c6e42,1275245,28e5f49a-24a8-422c-a905-907f764c6e42,2017-10-06T08:33:16.304824-05:00,a4fdbb589b5aa9c97581943754eb43db,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,39521cad-69a2-51a2-9806-31d8e5b12cbb,15c98cf6-12ac-5a85-81c0-216c6d226b14,TARGET-30-PANLET-01A-01R,aliquot
33,TARGET-30-PANNMS,Female,White,Not Hispanic or Latino,1080,Censored,3509.0,Alive,3509.0,2005,2014.0,"ANBL00B1, A3973, ANBL0032",Stage 4,Not Amplified,Hyperdiploid (DI>1),2.0,Unfavorable,Unknown,Unknown,Neuroblastoma,C48.0,Retroperitoneum  Periadrenal tissue  Perinephric tissue  Peripancreatic tissue  Perirenal tissue  Retrocecal tissue  Retroperitoneal tissue,High Risk,90-95,5,,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,d8d936d7-5483-48ab-90af-c5e5fa675d9b.htseq.counts,test_version138_GeneExpressionCounts,09ab195a-d931-4596-975b-3551100900f2,1263959,09ab195a-d931-4596-975b-3551100900f2,2017-10-06T08:32:06.875552-05:00,8132f34e7128eec2c12e226c8a660f98,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,e3c1e6b8-9ecf-5944-8be5-3aefce296374,9d9771ca-7e29-586c-8f7a-005b3b08aadc,TARGET-30-PANNMS-01A-01R,aliquot
34,TARGET-30-PANRRW,Male,White,Not Hispanic or Latino,1730,Relapse,408.0,Alive,2178.0,2005,2011.0,"ANBL00B1, A3973, ANBL0032, ANBL0322",Stage 4,Not Amplified,Diploid (DI=1),1.0,Unfavorable,Unknown,Unknown,Neuroblastoma,C76.2,"Abdomen, NOS  Abdominal wall, NOS  Intra-abdominal site, NOS",High Risk,,,,,Bone Marrow BMA neg. BMbiopsy r side pos.,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,58fb41e7-6659-4483-96ab-28c086f21d9f.htseq.counts,test_version105_GeneExpressionCounts,0b611938-6433-4ca3-b4c9-774414c70b25,1278248,0b611938-6433-4ca3-b4c9-774414c70b25,2017-10-06T08:29:48.873012-05:00,77d72f998e6e061785628400e56a9fb9,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,f5a45dcd-f87d-5c08-975c-55d9780d1ed1,96dc4259-17a0-5bb6-bf69-be8d6a6a1891,TARGET-30-PANRRW-01A-01R,aliquot
35,TARGET-30-PANRVJ,Male,White,Not Hispanic or Latino,4781,Censored,3722.0,Alive,3722.0,2005,2015.0,"ANBL00B1, ANBL0032, ALTE03N1",Stage 4,Not Amplified,Hyperdiploid (DI>1),1.35,Unfavorable,Differentiating,Intermediate,Neuroblastoma,C76.2,"Abdomen, NOS  Abdominal wall, NOS  Intra-abdominal site, NOS",High Risk,,,,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,6790b6ce-1be7-420a-b08b-1d9ce8fad4a3.htseq.counts,test_version53_GeneExpressionCounts,fad24504-b3d5-4ea1-b9d4-5a480c827188,1276282,fad24504-b3d5-4ea1-b9d4-5a480c827188,2017-10-06T08:25:37.569933-05:00,f7b7131641e52109f3f12bc38321a1d4,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,11a4aadd-d46e-59ab-9293-ea96973b1668,dcee4817-86fa-59ea-b33c-679662b2d2c8,TARGET-30-PANRVJ-01A-01R,aliquot
36,TARGET-30-PANSBN,Male,White,Not Hispanic or Latino,2329,Relapse,505.0,Dead,836.0,2005,2007.0,ANBL00B1,Stage 4,Not Amplified,Diploid (DI=1),1.0,Unfavorable,Differentiating,High,"Ganglioneuroblastoma, nodular",C38.3,"Mediastinum, NOS",High Risk,,,,,Bone Marrow,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,6892ab76-6690-4da1-83a7-c9ce5e19eb22.htseq.counts,test_version98_GeneExpressionCounts,c072f502-1ae8-42a7-ac80-3982f01586c6,1268868,c072f502-1ae8-42a7-ac80-3982f01586c6,2017-10-06T08:29:01.889718-05:00,2f9d8ff0bd2a3a59c10381d4d1559b30,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,cbf534b2-3d0e-53e7-b805-68e928f44c90,1399e2fd-a8b3-5238-9eb7-80afebc9f657,TARGET-30-PANSBN-01A-01R,aliquot
37,TARGET-30-PANUIF,Female,White,Not Hispanic or Latino,2234,Censored,3726.0,Alive,3726.0,2005,2015.0,"ANBL00B1, A3973, ANBL0032",Stage 4,Not Amplified,Diploid (DI=1),1.0,Unfavorable,Undifferentiated or Poorly Differentiated,Low,Neuroblastoma,C76.2,"Abdomen, NOS  Abdominal wall, NOS  Intra-abdominal site, NOS",High Risk,,,,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,ace0c57d-c209-4e59-a8d7-c26cf72bce1a.htseq.counts,test_version141_GeneExpressionCounts,853c6091-72c5-43bd-a105-843ed703f21d,1274437,853c6091-72c5-43bd-a105-843ed703f21d,2017-10-06T08:32:30.320255-05:00,503861ff2b0178607599bf1b3364cfc7,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,5cb93e56-bbf1-580f-8a28-3a2b2c4c6740,1431dd24-bd56-51e3-bf5d-160635a4946e,TARGET-30-PANUIF-01A-01R,aliquot
38,TARGET-30-PANWRR,Male,White,Not Hispanic or Latino,2937,Progression,267.0,Dead,345.0,2005,2006.0,"ANBL00B1, A3973",Stage 4,Not Amplified,Diploid (DI=1),1.0,Unfavorable,Differentiating,Low,Neuroblastoma,C76.2,"Abdomen, NOS  Abdominal wall, NOS  Intra-abdominal site, NOS",High Risk,,,,,Lymph Nodes,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,671c70da-e21e-4dd6-bcbd-6ed30fb78278.htseq.counts,test_version145_GeneExpressionCounts,cc850b19-1d54-4794-a7c6-c6eaacd1dfc2,1271377,cc850b19-1d54-4794-a7c6-c6eaacd1dfc2,2017-10-06T08:32:53.477865-05:00,b8ed682f26ce52c0f70ffdecb5c2f97b,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,7004b0e7-a614-5ce8-8e32-306f17929e49,d61abc8d-c674-58f2-af83-d18706e03514,TARGET-30-PANWRR-01A-01R,aliquot
39,TARGET-30-PANXJL,Male,Unknown,Unknown,5734,Censored,431.0,Alive,431.0,2005,2006.0,ANBL00B1,Stage 4,Not Amplified,Hyperdiploid (DI>1),1.24,Unfavorable,Undifferentiated or Poorly Differentiated,Low,"Ganglioneuroblastoma, nodular",C77.5,Pelvic lymph nodes  Hypogastric lymph node  Iliac lymph node  Inferior epigastric lymph node  Intrapelvic lymph node  Obturator lymph node  Paracervical lymph node  Parametrial lymph node  Presymphysial lymph node  Sacral lymph node,High Risk,,,,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,44643665-e3b2-4d0d-990b-c1ef6c50b00b.htseq.counts,test_version25_GeneExpressionCounts,c8769309-dfac-4fa0-ac97-4b44edc9db7d,1270212,c8769309-dfac-4fa0-ac97-4b44edc9db7d,2017-10-06T08:23:42.670826-05:00,951b23be4cded6884dbb82fd90ada756,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,cb780444-1ce8-555d-b973-b2f90eea647e,e40c2997-8ab1-5ced-ae7f-bb00e578a06a,TARGET-30-PANXJL-01A-01R,aliquot
40,TARGET-30-PANYGR,Male,Unknown,Not Hispanic or Latino,993,Progression,281.0,Dead,283.0,2005,2006.0,ANBL00B1,Stage 4,Not Amplified,Diploid (DI=1),1.0,Unfavorable,Undifferentiated or Poorly Differentiated,Unknown,Neuroblastoma,C48.8,Overlapping lesion of retroperitoneum and peritoneum  (See note page 1),High Risk,,,,,Primary Site; Bone; Other Metastatic Sites,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,df7a35a0-dc6a-4801-a962-be2e171eb773.htseq.counts,test_version113_GeneExpressionCounts,42e75ea9-0d88-4fb5-ab0d-909a8a512a47,1273965,42e75ea9-0d88-4fb5-ab0d-909a8a512a47,2017-10-06T08:30:12.040966-05:00,b9091558c22abdc7adf713b16f96b5df,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,6ee697db-9360-5214-9d48-58c7e03dcc43,7d624f31-49fa-55d7-a0a1-6b32cc17a333,TARGET-30-PANYGR-01A-01R,aliquot
41,TARGET-30-PANZPV,Female,White,Hispanic or Latino,1757,Relapse,1013.0,Dead,1261.0,2005,2009.0,ANBL00B1,Stage 4,Not Amplified,Diploid (DI=1),1.0,Unfavorable,Unknown,Unknown,Neuroblastoma,C22.0,"Liver  Hepatic, NOS",High Risk,,,,,Primary Site; Bone Marrow; Other Metastatic Sites,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,0a01a5ee-1df4-405e-8eb6-98fa0a480ace.htseq.counts,test_version61_GeneExpressionCounts,ed425d32-b56f-4884-b54b-d49c5a73853c,1269986,ed425d32-b56f-4884-b54b-d49c5a73853c,2017-10-06T08:26:21.324309-05:00,94df9edf9c73550e5dd4779f551e75cf,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,4d95a85e-7c10-522b-8bfa-99cfade52d37,eb8c226d-477a-5922-b6ee-c01c812453c0,TARGET-30-PANZPV-01A-01R,aliquot
42,TARGET-30-PANZRV,Male,White,Not Hispanic or Latino,72,Censored,3434.0,Alive,3434.0,2005,2015.0,ANBL00B1,Stage 4s,Not Amplified,Hyperdiploid (DI>1),2.5,Favorable,Undifferentiated or Poorly Differentiated,Intermediate,Neuroblastoma,C74.9," Adrenal gland, NOS

Suprarenal gland

Adrenal, NOS",Low Risk,,,,,,,,,hyperdiploid miscoded as diploid/hypodiploid in previous update,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,c7ac5a3e-b090-4882-9dca-94f55e3f7fa4.htseq.counts,test_version51_GeneExpressionCounts,fbc0b227-750b-4028-b00f-7da13fc09215,1271544,fbc0b227-750b-4028-b00f-7da13fc09215,2017-10-06T08:25:37.569933-05:00,7e0ab05d2a1e9ecd75978bf0e80affa9,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,c732484c-b50c-5869-9c44-287a25004951,68a47b6c-e83d-59cc-b0ec-8825d31f68f5,TARGET-30-PANZRV-01A-01R,aliquot
43,TARGET-30-PANZVU,Male,White,Not Hispanic or Latino,1713,Death,934.0,Dead,934.0,2005,2008.0,"ANBL00B1, A3973",Stage 4,Not Amplified,Hyperdiploid (DI>1),1.2,Unfavorable,Unknown,Unknown,Neuroblastoma,C74.9,"Adrenal gland, NOS  Suprarenal gland  Adrenal, NOS",High Risk,,,,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,2d14958e-806f-43fc-abac-69e5545c895a.htseq.counts,test_version60_GeneExpressionCounts,d3947906-9987-4ab7-bf67-fd96d5755b04,1274265,d3947906-9987-4ab7-bf67-fd96d5755b04,2017-10-06T08:26:21.324309-05:00,1409c6937776889487ab2bf34077d418,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,d621e405-d1d7-509b-9f51-d60741a0cae5,a6b0ef73-dad5-503b-8692-eb23d8c9ffa4,TARGET-30-PANZVU-01A-01R,aliquot
44,TARGET-30-PAPBGH,Female,Native Hawaiian or other Pacific Islander,Not Hispanic or Latino,1074,Relapse,470.0,Dead,723.0,2005,2007.0,"ANBL00B1, A3973, ANBL0032",Stage 4,Not Amplified,Diploid (DI=1),1.0,Unfavorable,Undifferentiated or Poorly Differentiated,Unknown,Neuroblastoma,C74.9,"Adrenal gland, NOS  Suprarenal gland  Adrenal, NOS",High Risk,,,,,"Other, specify: Right temporal lobe metastasis - right skull with mass effect.",,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,86804d13-b05b-4c23-8e83-653fc4212de7.htseq.counts,test_version144_GeneExpressionCounts,ea4faf2f-070c-4346-9681-b23e31ea7c34,1271494,ea4faf2f-070c-4346-9681-b23e31ea7c34,2017-10-06T08:32:30.320255-05:00,4c4be1c2453447076ef6f77a7c97aded,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,d0cf351c-7617-5e85-9d46-f534bd311c37,58cb79fe-0993-5900-af35-681d47c4565e,TARGET-30-PAPBGH-01A-01R,aliquot
45,TARGET-30-PAPBJE,Male,White,Not Hispanic or Latino,1860,Censored,3467.0,Alive,3467.0,2005,2015.0,"AADM01P1, ANBL00B1, A3973, ALTE05N1",Stage 4,Amplified,Diploid (DI=1),1.0,Unfavorable,Undifferentiated or Poorly Differentiated,High,Neuroblastoma,C64.9,"Kidney, NOS  Renal, NOS  Kidney parenchyma",High Risk,,,,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,9d0e0be5-16a6-4898-bb6b-08113ca10cde.htseq.counts,test_version106_GeneExpressionCounts,7fd79bc2-bd6a-4845-9abd-18d77db964b0,1270423,7fd79bc2-bd6a-4845-9abd-18d77db964b0,2017-10-06T08:29:48.873012-05:00,8e9fb507c563b7379add35199dbefb22,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,88da9cb9-9373-51be-8e37-ba2372edbaec,f9718b6b-aaa1-5543-93c7-6cf6d931a275,TARGET-30-PAPBJE-01A-01R,aliquot
46,TARGET-30-PAPBZI,Male,White,Not Hispanic or Latino,1710,Progression,172.0,Dead,430.0,2005,2007.0,"ANBL00B1, A3973",Stage 4,Not Amplified,Hyperdiploid (DI>1),1.99,Unfavorable,Unknown,Unknown,Neuroblastoma,C76.2,"Abdomen, NOS  Abdominal wall, NOS  Intra-abdominal site, NOS",High Risk,,,,,Bone,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,e6e480c6-9af2-4afe-8b30-d869c635fdb7.htseq.counts,test_version30_GeneExpressionCounts,0dd39e9e-aa3e-4dc7-aa4d-e1abca583679,1268389,0dd39e9e-aa3e-4dc7-aa4d-e1abca583679,2017-10-06T08:24:05.575877-05:00,97081d71bd49ca82e3d240e534e55659,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,ffbc6086-8563-5b50-ab6c-3c19b7caa594,c31ee5c6-0122-5053-9fcb-764a719b820f,TARGET-30-PAPBZI-01A-01R,aliquot
47,TARGET-30-PAPCTS,Male,Black or African American,Not Hispanic or Latino,2008,Relapse,2236.0,Dead,2636.0,2005,2013.0,ANBL00B1,Stage 4,Amplified,Diploid (DI=1),1.0,Unfavorable,Undifferentiated or Poorly Differentiated,Unknown,Neuroblastoma,C64.9,"Kidney, NOS  Renal, NOS  Kidney parenchyma",High Risk,,,,,Bone; Bone Marrow; Other Metastatic Sites,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,b9987cb1-394a-4ab3-96b9-e06bbcd6e31e.htseq.counts,test_version114_GeneExpressionCounts,d6ebfd02-7d77-47db-86ab-ee26cc43018e,1272312,d6ebfd02-7d77-47db-86ab-ee26cc43018e,2017-10-06T08:30:12.040966-05:00,83dae7779d7f0bcdc6edeab7901d7004,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,29c3a4ac-24e8-56c6-b43b-8e1dfb4d010d,7a38d552-70f6-55b0-8c31-1ee7e5ab171c,TARGET-30-PAPCTS-01A-01R,aliquot
48,TARGET-30-PAPEFE,Male,Black or African American,Not Hispanic or Latino,990,Progression,138.0,Dead,150.0,2005,2006.0,"ANBL00B1, A3973",Stage 4,Amplified,Diploid (DI=1),1.0,Unfavorable,Undifferentiated or Poorly Differentiated,Intermediate,Neuroblastoma,C74.9,"Adrenal gland, NOS  Suprarenal gland  Adrenal, NOS",High Risk,,,,,Primary Site; Lung (parenchymal),,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,26c392ed-b4ff-49d5-a2c2-8979a7563b96.htseq.counts,test_version71_GeneExpressionCounts,eb02c79a-5561-45c2-a962-f89bf5951efd,1272477,eb02c79a-5561-45c2-a962-f89bf5951efd,2017-10-06T08:27:10.511052-05:00,7e49c8bb8b031d266cc178f4f538ade2,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,55a76269-7460-5204-9ad5-684d9eb18f24,6d70e9cc-aa35-5a12-baae-3e32a9446b2a,TARGET-30-PAPEFE-01A-01R,aliquot
49,TARGET-30-PAPHPE,Male,Black or African American,Not Hispanic or Latino,806,Relapse,453.0,Dead,470.0,2006,2007.0,ANBL00B1,Stage 4,Not Amplified,Hyperdiploid (DI>1),1.13,Unfavorable,Unknown,Unknown,Neuroblastoma,C76.2,"Abdomen, NOS  Abdominal wall, NOS  Intra-abdominal site, NOS",High Risk,90,10,98/2,,Primary Site; Other Metastatic Sites,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,9704403e-aaf9-4a97-99bc-b2a9a9861767.htseq.counts,test_version90_GeneExpressionCounts,41af5af9-2a4a-49c0-81a1-39ae9fd5417a,1273381,41af5af9-2a4a-49c0-81a1-39ae9fd5417a,2017-10-06T08:28:39.214953-05:00,c634f12989231eefb618ca5e3f8e8683,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,bde95322-bb48-5902-93a5-f0aab47dcf0a,d8d35240-b135-5dad-b992-05be7e883fc2,TARGET-30-PAPHPE-01A-01R,aliquot
50,TARGET-30-PAPICY,Female,White,Not Hispanic or Latino,58,Censored,205.0,Alive,205.0,2006,2006.0,ANBL00B1,Stage 4s,Not Amplified,Hyperdiploid (DI>1),1.31,Favorable,Undifferentiated or Poorly Differentiated,Intermediate,Neuroblastoma,C44.7," Skin of lower limb and hip

Skin of:

. Ankle

. Calf

. Foo",Low Risk,,,,,,,,,hyperdiploid miscoded as diploid/hypodiploid in previous update,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,19709a7e-d7ae-45db-a8e6-5424c08e6dd6.htseq.counts,test_version159_GeneExpressionCounts,9b11d3a2-a193-4fdb-befa-f0cfd712338e,1272581,9b11d3a2-a193-4fdb-befa-f0cfd712338e,2017-10-06T08:33:38.856860-05:00,f69d703df8d061590fbbe0bf791c101d,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,236fd222-ec1a-5ff9-8b97-6fd508d0c719,c18f2394-5fac-5aef-b36e-6ca61ef1158d,TARGET-30-PAPICY-01A-01R,aliquot
51,TARGET-30-PAPKWN,Female,White,Unknown,710,Relapse,260.0,Dead,465.0,2006,2007.0,ANBL00B1,Stage 4,Amplified,Hyperdiploid (DI>1),1.6,Unfavorable,Undifferentiated or Poorly Differentiated,High,Neuroblastoma,C76.0,"Head, face or neck, NOS  Cheek, NOS  Jaw, NOS  Nose, NOS  Cervical region, NOS  Supraclavicular region, NOS",High Risk,,,,,Bone Marrow,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,f99e2b20-96d7-49f3-bdd2-7a1cf2fa6208.htseq.counts,test_version39_GeneExpressionCounts,df298b13-5ac4-4089-9a1a-0b6471ab93a5,1268206,df298b13-5ac4-4089-9a1a-0b6471ab93a5,2017-10-06T08:24:28.919403-05:00,c22c9dcbe0bb44269c0d56fbf2934ca8,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,097d3688-cb90-5073-8aed-7c6286cf7a1d,ab3d4eec-32cf-56be-a7f0-fcd4ecf6c423,TARGET-30-PAPKWN-01A-01R,aliquot
52,TARGET-30-PAPKXS,Female,White,Not Hispanic or Latino,2547,Relapse,978.0,Dead,2384.0,2006,2012.0,"ANBL00B1, ADVL0821",Stage 4,Not Amplified,Hyperdiploid (DI>1),1.1,Unfavorable,Undifferentiated or Poorly Differentiated,Intermediate,Neuroblastoma,C74.9,"Adrenal gland, NOS  Suprarenal gland  Adrenal, NOS",High Risk,,,,,Other Metastatic Sites,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,626adafd-e4a3-477b-8ad3-48ed04d4d95c.htseq.counts,test_version48_GeneExpressionCounts,068741d6-9334-4fc6-8310-7aefdc1e7b04,1278543,068741d6-9334-4fc6-8310-7aefdc1e7b04,2017-10-06T08:25:15.152144-05:00,747bd4c92600e8c00fa27ec5bbe924be,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,cd8b70b6-2946-5323-a407-56df7e9a70c1,b7958083-bd6f-5f3d-b31b-b31f95289bfa,TARGET-30-PAPKXS-01A-01R,aliquot
53,TARGET-30-PAPLSD,Male,White,Not Hispanic or Latino,710,Relapse,583.0,Dead,1383.0,2006,2010.0,"ANBL00B1, ANBL0421",Stage 4,Not Amplified,Diploid (DI=1),1.0,Unknown,Unknown,Unknown,Neuroblastoma,C76.2,"Abdomen, NOS  Abdominal wall, NOS  Intra-abdominal site, NOS",High Risk,20,75,20/80,,"Other, specify: brain",,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,7b6e55b7-ffed-4d53-baee-55f791069424.htseq.counts,test_version84_GeneExpressionCounts,81b291b9-94c1-44ae-a8fb-af016fda16a0,1270878,81b291b9-94c1-44ae-a8fb-af016fda16a0,2017-10-06T08:27:57.735394-05:00,354cba379572cc9dec2c2cfe1b4e6565,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,e84a2bdf-58d4-5525-b729-c8d84db77e3e,4348cb1f-5b31-5e87-935b-e288def67407,TARGET-30-PAPLSD-01A-01R,aliquot
54,TARGET-30-PAPTAN,Male,Black or African American,Not Hispanic or Latino,1462,Censored,2054.0,Alive,2054.0,2006,2012.0,ANBL00B1,Stage 4,Not Amplified,Hyperdiploid (DI>1),1.18,Unfavorable,Unknown,Unknown,"Ganglioneuroblastoma, nodular",C38.2,Posterior mediastinum,High Risk,40,20,40/60,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,b1623fd7-b407-4a82-910d-c0e57518e608.htseq.counts,test_version43_GeneExpressionCounts,3b1b9bbd-c177-406a-b81c-d8baf1ba9257,1276366,3b1b9bbd-c177-406a-b81c-d8baf1ba9257,2017-10-06T08:24:52.252607-05:00,d07cbb316231d0f03395866ba64e195b,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,c4d76cbd-7bdd-52ac-b9c6-fa6c94c9c92e,2d4ad426-65bc-59e7-8250-76bfc20290d7,TARGET-30-PAPTAN-01A-01R,aliquot
55,TARGET-30-PAPTCR,Female,White,Not Hispanic or Latino,754,Event,394.0,Dead,456.0,2006,2007.0,"ANBL00B1, ANBL0621",Stage 4,Unknown,Unknown,,Unknown,Unknown,Unknown,Neuroblastoma,C74.9,"Adrenal gland, NOS  Suprarenal gland  Adrenal, NOS",High Risk,20,10,20/80,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,ae90fe2e-b857-463a-be07-b4ad9babc334.htseq.counts,test_version95_GeneExpressionCounts,0fc032d0-0bd8-4220-b258-b53f818fb09d,1275300,0fc032d0-0bd8-4220-b258-b53f818fb09d,2017-10-06T08:29:01.889718-05:00,06822749ee9ee08c276bfd5517fde275,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,551b7a24-9df7-5302-bfbc-addccca13fe3,e6a3ed7a-8517-59b7-8814-b35ba41f08a2,TARGET-30-PAPTCR-01A-01R,aliquot
56,TARGET-30-PAPTDH,Female,White,Not Hispanic or Latino,11,Second Malignant Neoplasm,193.0,Alive,3264.0,2006,2015.0,ANBL00B1,Stage 4s,Not Amplified,Hyperdiploid (DI>1),1.1,Favorable,Undifferentiated or Poorly Differentiated,Low,Neuroblastoma,C74.9," Adrenal gland, NOS

Suprarenal gland

Adrenal, NOS",Low Risk,40,30,40/60,,,,,,hyperdiploid miscoded as diploid/hypodiploid in previous update,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,4803fc06-e2de-44aa-b76e-f8fe9308c18d.htseq.counts,test_version94_GeneExpressionCounts,799d8654-63f1-4b14-aab0-45276e23e42c,1273919,799d8654-63f1-4b14-aab0-45276e23e42c,2017-10-06T08:28:39.214953-05:00,c57795ebcc8f65ab0f43e45724b59cee,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,9dee1023-20e1-5c84-92ac-358d1e113b1b,46ba5391-5a85-5250-9823-4b34a6122377,TARGET-30-PAPTDH-01A-01R,aliquot
57,TARGET-30-PAPTLV,Female,White,Not Hispanic or Latino,641,Relapse,366.0,Dead,575.0,2006,2008.0,ANBL00B1,Stage 4,Amplified,Diploid (DI=1),1.0,Unfavorable,Undifferentiated or Poorly Differentiated,Low,Neuroblastoma,C74.9,"Adrenal gland, NOS  Suprarenal gland  Adrenal, NOS",High Risk,,,,,"Bone; Other, specify: Liver and Lungs",,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,b2b0bec1-334c-4b94-a9d8-81206911dd42.htseq.counts,test_version153_GeneExpressionCounts,0738e26d-942f-4ce2-b0ed-f0bc7428d05e,1270419,0738e26d-942f-4ce2-b0ed-f0bc7428d05e,2017-10-06T08:33:16.304824-05:00,da069ac320532794c2f30e4f334963ce,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,aa1eb195-f57f-5990-9b89-e9b382961162,ac5bf7fe-bc33-5568-8f86-66ae018ef84f,TARGET-30-PAPTLV-01A-01R,aliquot
58,TARGET-30-PAPUEB,Female,White,Not Hispanic or Latino,1595,Censored,2772.0,Alive,2772.0,2006,2014.0,ANBL00B1,Stage 4,Not Amplified,Hyperdiploid (DI>1),2.18,Unfavorable,Undifferentiated or Poorly Differentiated,Unknown,Neuroblastoma,C76.2,"Abdomen, NOS  Abdominal wall, NOS  Intra-abdominal site, NOS",High Risk,40,5,40/60,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,692a3229-af33-4136-bc6e-a4b22f016cde.htseq.counts,test_version18_GeneExpressionCounts,297f42e7-e602-4104-b28a-bd2cd44787ca,1274198,297f42e7-e602-4104-b28a-bd2cd44787ca,2017-10-06T08:23:00.878915-05:00,7c8c1ae8b05b87313878e9cf8c5ab5a7,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,7c5d9570-99f4-52a2-a14e-02e2eaf56ac6,6ea6a9ad-080d-5d37-ad34-103ac43d4536,TARGET-30-PAPUEB-01A-01R,aliquot
59,TARGET-30-PAPUNH,Female,White,Not Hispanic or Latino,3425,Censored,2958.0,Alive,2958.0,2006,2014.0,ANBL00B1,Stage 3,Amplified,Hyperdiploid (DI>1),1.77,Unfavorable,Undifferentiated or Poorly Differentiated,High,Neuroblastoma,C48.0,Retroperitoneum  Periadrenal tissue  Perinephric tissue  Peripancreatic tissue  Perirenal tissue  Retrocecal tissue  Retroperitoneal tissue,High Risk,30,5,30/70,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,250ed70c-1090-459e-b17e-c6420e1c39de.htseq.counts,test_version128_GeneExpressionCounts,29e99565-f4c0-4a55-acc7-4bf6cd0a5fd2,1275075,29e99565-f4c0-4a55-acc7-4bf6cd0a5fd2,2017-10-06T08:31:18.033493-05:00,184b5b15dee70cdcc41c2df505fc0646,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,da61d824-bd70-5a6c-a693-e823e3a11c05,67260de6-397d-5a93-9576-071c6b280204,TARGET-30-PAPUNH-01A-01R,aliquot
60,TARGET-30-PAPUWY,Female,White,Not Hispanic or Latino,1955,Relapse,765.0,Dead,1102.0,2006,2009.0,"ANBL00B1, ANBL0621",Stage 4,Not Amplified,Diploid (DI=1),1.0,Unfavorable,Undifferentiated or Poorly Differentiated,High,Neuroblastoma,C74.9,"Adrenal gland, NOS  Suprarenal gland  Adrenal, NOS",High Risk,40,10,40/60,,"Bone; Other Metastatic Sites; Other, specify: Left supraclavicular region with hilar, pretracheal, and subcarinal lymph nodes.
MIBG scan positive for metastases in right pelvis, bilateral proximal femora, midvertebral column, left lung apex, left thigh and skull.",,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,c863478e-1746-43f1-8e1e-d87e0cc101ef.htseq.counts,test_version85_GeneExpressionCounts,6bc1eb63-0ae0-49f2-9777-9ca7bb261fe5,1276293,6bc1eb63-0ae0-49f2-9777-9ca7bb261fe5,2017-10-06T08:28:17.762914-05:00,ecd4dded713b34d3a11fdb554bf6fed0,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,cff34706-f3b7-54d6-8e43-8d0cbd25126c,95d7372e-2734-5068-8f7d-7597d92c1737,TARGET-30-PAPUWY-01A-01R,aliquot
61,TARGET-30-PAPVEB,Male,White,Not Hispanic or Latino,1720,Relapse,263.0,Dead,1211.0,2006,2010.0,"ANBL00B1, ANBL0621",Stage 2b,Not Amplified,Hyperdiploid (DI>1),1.12,Unfavorable,Differentiating,Intermediate,Neuroblastoma,C74.9," Adrenal gland, NOS

Suprarenal gland

Adrenal, NOS",Low Risk,60,10,60/40,,Bone; Bone Marrow,90,,,hyperdiploid miscoded as diploid/hypodiploid in previous update,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,00e47068-3dcc-4b3d-ba10-8371a1d33cbc.htseq.counts,test_version4_GeneExpressionCounts,38a2331f-9559-483c-b6dc-4f4028fb6aab,1260762,38a2331f-9559-483c-b6dc-4f4028fb6aab,2017-10-06T08:21:49.750654-05:00,c4562fa245d7b52f13a3a456f9b9008d,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,6518e037-e044-5bdf-8336-63816449c73f,865d47cc-815f-5f64-ad3c-68026de20912,TARGET-30-PAPVEB-04A-01R,aliquot
62,TARGET-30-PAPVFD,Male,White,Not Hispanic or Latino,1961,Death,1765.0,Dead,1765.0,2006,2011.0,ANBL00B1,Stage 4,Not Amplified,Hyperdiploid (DI>1),1.11,Unfavorable,Unknown,Unknown,Neuroblastoma,C74.1,Medulla of adrenal gland,High Risk,90,10,90/10,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,6508e923-51d3-41a3-9fe4-dbe7a7fe7139.htseq.counts,test_version147_GeneExpressionCounts,b1cc1842-e490-4706-a79e-62cf429923cd,1276333,b1cc1842-e490-4706-a79e-62cf429923cd,2017-10-06T08:32:53.477865-05:00,f0aa165a1ac43071fbb2e76ef0df25f1,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,9a506427-54ae-5a83-b5b0-2c5219a3fca3,e2a7ddf6-6ecc-5522-b538-0967bc164881,TARGET-30-PAPVFD-01A-01R,aliquot
63,TARGET-30-PAPVRN,Male,White,Not Hispanic or Latino,2300,Censored,2889.0,Alive,2889.0,2006,2014.0,ANBL00B1,Stage 4,Not Amplified,Hyperdiploid (DI>1),1.19,Unfavorable,Differentiating,Low,"Ganglioneuroblastoma, nodular",C76.2,"Abdomen, NOS  Abdominal wall, NOS  Intra-abdominal site, NOS",High Risk,30,,,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,fa2e0b15-1ed1-462c-991f-2e279493dba1.htseq.counts,test_version100_GeneExpressionCounts,285cd8bc-2ed3-43d0-a2ec-d880dda6a306,1270551,285cd8bc-2ed3-43d0-a2ec-d880dda6a306,2017-10-06T08:29:25.488029-05:00,f3eef07da55250f1d2fd204b48dbdbc3,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,e72d1f9b-f4f0-555b-b4e3-0f5783f11ed4,6978c6f8-9b9b-56aa-9644-83ef68155112,TARGET-30-PAPVRN-01A-01R,aliquot
64,TARGET-30-PAPVXS,Male,Black or African American,Not Hispanic or Latino,1366,Death,224.0,Dead,224.0,2006,2007.0,ANBL00B1,Stage 4,Not Amplified,Diploid (DI=1),1.0,Unfavorable,Undifferentiated or Poorly Differentiated,High,Neuroblastoma,C74.9,"Adrenal gland, NOS  Suprarenal gland  Adrenal, NOS",High Risk,80,10,80/20,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,6ad1f4f9-dec0-4ded-8391-45efeb7ffe8d.htseq.counts,test_version93_GeneExpressionCounts,532fd713-e9b0-4074-8fe9-3a652d5c71cb,1276323,532fd713-e9b0-4074-8fe9-3a652d5c71cb,2017-10-06T08:28:39.214953-05:00,cb4e5fc7388f6a76df188481e9ba71cc,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,4119296d-d9c4-501b-8eaa-b0a6f6263a6e,f6a0f54a-c9f8-513a-b26c-ed1316f2615d,TARGET-30-PAPVXS-01A-01R,aliquot
65,TARGET-30-PAPZYP,Female,White,Hispanic or Latino,1010,Censored,2386.0,Alive,2386.0,2007,2013.0,ANBL00B1,Stage 4,Amplified,Diploid (DI=1),1.0,Unfavorable,Undifferentiated or Poorly Differentiated,Unknown,Neuroblastoma,C48.0,Retroperitoneum  Periadrenal tissue  Perinephric tissue  Peripancreatic tissue  Perirenal tissue  Retrocecal tissue  Retroperitoneal tissue,High Risk,90,10,90/10,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,b1893955-2d73-4d1f-967a-22664fbd494b.htseq.counts,test_version123_GeneExpressionCounts,1a225f23-384a-4197-9e02-b35ebc187f14,1274169,1a225f23-384a-4197-9e02-b35ebc187f14,2017-10-06T08:30:54.984868-05:00,67a076587a5df2a64aca839f08e0ed0d,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,07344452-e5b5-529e-921e-24d18804c6c0,c52c5d78-4404-5917-b9d5-d372e9f22f22,TARGET-30-PAPZYP-01A-01R,aliquot
66,TARGET-30-PAPZYZ,Female,Black or African American,Not Hispanic or Latino,550,Censored,1209.0,Alive,1209.0,2007,2010.0,"ANBL00B1, ANBL0032",Stage 4,Amplified,Hyperdiploid (DI>1),1.68,Unknown,Unknown,Unknown,Neuroblastoma,C48.0,Retroperitoneum  Periadrenal tissue  Perinephric tissue  Peripancreatic tissue  Perirenal tissue  Retrocecal tissue  Retroperitoneal tissue,High Risk,60,,60/40,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,e21dce4f-7e4e-44e7-8e38-4353d59125e6.htseq.counts,test_version132_GeneExpressionCounts,934f75b2-2202-4c91-b871-32bd1200881c,1269848,934f75b2-2202-4c91-b871-32bd1200881c,2017-10-06T08:31:43.284163-05:00,491f14f01bc1282880d56fdb4a5de21b,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,674d64a5-c017-546e-a94d-adbf7aab3826,6f498de5-f8f4-5500-aebe-3e290cc755e4,TARGET-30-PAPZYZ-01A-01R,aliquot
67,TARGET-30-PARACM,Female,Black or African American,Not Hispanic or Latino,1442,Censored,2994.0,Alive,2994.0,2007,2015.0,ANBL00B1,Stage 4,Not Amplified,Hyperdiploid (DI>1),1.8,Unfavorable,Undifferentiated or Poorly Differentiated,High,"Ganglioneuroblastoma, nodular",C74.9,"Adrenal gland, NOS  Suprarenal gland  Adrenal, NOS",High Risk,10-20,10,10-20/80-90,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,9df25fe5-9aa3-4097-ad77-dd0139716b59.htseq.counts,test_version41_GeneExpressionCounts,be2e81fb-8b9d-4bda-b4de-15b9df9ffbef,1277688,be2e81fb-8b9d-4bda-b4de-15b9df9ffbef,2017-10-06T08:24:52.252607-05:00,8ffea4f867808cdb4d80474333bc84d0,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,120d9030-0a4c-56b1-918e-894819d87fe5,87ebdd42-62ac-5115-b0b1-413e6823b4d0,TARGET-30-PARACM-01A-01R,aliquot
68,TARGET-30-PARACS,Male,White,Not Hispanic or Latino,1180,Censored,1328.0,Alive,1328.0,2007,2010.0,ANBL00B1,Stage 4,Not Amplified,Hyperdiploid (DI>1),1.16,Unfavorable,Undifferentiated or Poorly Differentiated,High,Neuroblastoma,C48.0,Retroperitoneum  Periadrenal tissue  Perinephric tissue  Peripancreatic tissue  Perirenal tissue  Retrocecal tissue  Retroperitoneal tissue,High Risk,80,10,80/20,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,7b36fef1-f02b-4294-b1b8-559808bbdbb6.htseq.counts,test_version11_GeneExpressionCounts,4962a8b1-717e-419d-9539-3c3e485f235d,1273119,4962a8b1-717e-419d-9539-3c3e485f235d,2017-10-06T08:22:37.905981-05:00,83cb0ce4267b47eb61183e51a1fb8b79,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,2b2cfe0c-52c0-5d1f-a97b-784078343f84,a3dca18d-714a-5e9f-815e-fae96b4441eb,TARGET-30-PARACS-01A-01R,aliquot
69,TARGET-30-PARAMT,Male,White,Not Hispanic or Latino,885,Death,493.0,Dead,493.0,2007,2008.0,ANBL00B1,Stage 4,Not Amplified,Hyperdiploid (DI>1),1.11,Unfavorable,Undifferentiated or Poorly Differentiated,Intermediate,"Ganglioneuroblastoma, nodular",C74.9,"Adrenal gland, NOS  Suprarenal gland  Adrenal, NOS",High Risk,80,10,80/20,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,7cccad17-8596-4032-9433-e293f2044d79.htseq.counts,test_version102_GeneExpressionCounts,b7a8cbc0-8ff5-4216-8a00-d7a238f22fcd,1275973,b7a8cbc0-8ff5-4216-8a00-d7a238f22fcd,2017-10-06T08:29:25.488029-05:00,46cc2b18d48ec8c66ed22eb625be0128,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,81877682-3b3e-51fd-9fe8-252a7d229310,a0a20fc0-40f1-5b6d-846b-53577eb41757,TARGET-30-PARAMT-01A-01R,aliquot
70,TARGET-30-PARBAJ,Male,White,Not Hispanic or Latino,35,Relapse,302.0,Alive,3122.0,2007,2015.0,ANBL00B1,Stage 3,Not Amplified,Hyperdiploid (DI>1),1.18,Favorable,Undifferentiated or Poorly Differentiated,Intermediate,Neuroblastoma,C48.0," Retroperitoneum

Periadrenal tissue

Perinephric tissue

Per",Intermediate Risk,,,,,Primary Site,40-85,0.0,,hyperdiploid miscoded as diploid/hypodiploid in previous update,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,0fc262f2-9c2e-4f28-af3f-337fccc68465.htseq.counts,test_version155_GeneExpressionCounts,0bce4a69-81ee-43b6-8fe7-126c3c1a61fd,1272758,0bce4a69-81ee-43b6-8fe7-126c3c1a61fd,2017-10-06T08:33:38.856860-05:00,cf94c7bcfc9b4ea68223f615a37b6a46,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,175bf29e-8b57-5474-8f74-87fd7a80a0c7,1210eafe-c2b3-5c4e-af31-552bd4ac9d5c,TARGET-30-PARBAJ-01A-01R,aliquot
71,TARGET-30-PARBAJ,Male,White,Not Hispanic or Latino,35,Relapse,302.0,Alive,3122.0,2007,2015.0,ANBL00B1,Stage 3,Not Amplified,Hyperdiploid (DI>1),1.18,Favorable,Undifferentiated or Poorly Differentiated,Intermediate,Neuroblastoma,C48.0," Retroperitoneum

Periadrenal tissue

Perinephric tissue

Per",Intermediate Risk,,,,,Primary Site,40-85,0.0,,hyperdiploid miscoded as diploid/hypodiploid in previous update,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,d3b3a2f3-d18f-494f-92b7-db15a14ccec4.htseq.counts,test_version7_GeneExpressionCounts,c7773978-db08-43a1-a099-4960602be5b0,1262126,c7773978-db08-43a1-a099-4960602be5b0,2017-10-06T08:22:14.253049-05:00,9822d61ebf343b982bc5376e56d8fa50,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,2a9b1baf-84fa-5dd2-bb0a-9ce9372373d2,1210eafe-c2b3-5c4e-af31-552bd4ac9d5c,TARGET-30-PARBAJ-02A-01R,aliquot
72,TARGET-30-PARBGP,Female,Black or African American,Not Hispanic or Latino,3625,Relapse,1524.0,Dead,2039.0,2007,2012.0,"ANBL00B1, ADVL0912",Stage 4,Not Amplified,Diploid (DI=1),1.0,Unfavorable,Undifferentiated or Poorly Differentiated,High,Neuroblastoma,C76.0,"Head, face or neck, NOS  Cheek, NOS  Jaw, NOS  Nose, NOS  Cervical region, NOS  Supraclavicular region, NOS",High Risk,70-80,10,70-80/20-30,,Primary Site,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,271dabcc-3b9e-4ebd-9a93-ca2ee6b9d863.htseq.counts,test_version117_GeneExpressionCounts,8f3ffcf3-3257-4078-a362-cd5e8f4ed2d2,1276329,8f3ffcf3-3257-4078-a362-cd5e8f4ed2d2,2017-10-06T08:30:35.588194-05:00,24e7b3095b372421623b9d644ee77def,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,346a5da1-592d-5ab7-b95b-28275db8812a,0aa03b3b-fa3c-574f-9811-1d208837a8f1,TARGET-30-PARBGP-01A-01R,aliquot
73,TARGET-30-PARDCK,Female,White,Not Hispanic or Latino,2060,Censored,2991.0,Alive,2991.0,2007,2015.0,"ANBL00B1, ANBL0032",Stage 4,Not Amplified,Hyperdiploid (DI>1),1.09,Unfavorable,Unknown,Unknown,"Ganglioneuroblastoma, nodular",C76.2,"Abdomen, NOS  Abdominal wall, NOS  Intra-abdominal site, NOS",High Risk,90,5,90/10,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,84b1ca2e-4732-426a-bbac-9720579ee30e.htseq.counts,test_version133_GeneExpressionCounts,f36367cf-412a-4e76-8219-11937f3143a3,1274319,f36367cf-412a-4e76-8219-11937f3143a3,2017-10-06T08:31:43.284163-05:00,d80709176f8105adaa4219baae56b67d,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,03021118-1b00-58ec-b90d-0d97d3ff5fe1,9a5f6a7f-95da-5979-b940-c57803dfc4f1,TARGET-30-PARDCK-01A-01R,aliquot
74,TARGET-30-PARDIW,Male,White,Not Hispanic or Latino,2048,Censored,2829.0,Alive,2829.0,2007,2015.0,ANBL00B1,Stage 4,Not Amplified,Hyperdiploid (DI>1),1.36,Unfavorable,Undifferentiated or Poorly Differentiated,Intermediate,Neuroblastoma,C76.2,"Abdomen, NOS  Abdominal wall, NOS  Intra-abdominal site, NOS",High Risk,10,90,10/90,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,7029a8f0-0bbe-4db1-9254-2517c87adba6.htseq.counts,test_version52_GeneExpressionCounts,89ccea22-f0f9-4601-b2c9-303bb83f6ae7,1272697,89ccea22-f0f9-4601-b2c9-303bb83f6ae7,2017-10-06T08:25:37.569933-05:00,0c5e84db6470e91490a43a399a7a4268,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,6d5a9cd8-0f91-5404-a819-d0ef2168a80b,cf8aee16-bf50-5f4b-8cac-4d10f772637e,TARGET-30-PARDIW-01A-01R,aliquot
75,TARGET-30-PARFRE,Female,Unknown,Unknown,60,Censored,2451.0,Alive,2451.0,2007,2014.0,ANBL00B1,Stage 4s,Not Amplified,Hyperdiploid (DI>1),1.46,Favorable,Unknown,Unknown,Neuroblastoma,C75.5," Aortic body and other paraganglia

Coccygeal body

Coccygeal",Low Risk,90,,,,,,,,hyperdiploid miscoded as diploid/hypodiploid in previous update,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,b1d954e7-21a0-441e-a9c7-47e6a6454625.htseq.counts,test_version149_GeneExpressionCounts,247b1359-ccba-4636-aad3-f1788b033d67,1272127,247b1359-ccba-4636-aad3-f1788b033d67,2017-10-06T08:32:53.477865-05:00,7e8fd2254b61de7961ff967fe5fefd61,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,2740b0ec-afc3-51a9-96d4-738fe28e1e15,2660b19b-084d-59f8-b1b9-8323a46198ca,TARGET-30-PARFRE-01A-01R,aliquot
76,TARGET-30-PARFWB,Male,White,Not Hispanic or Latino,1555,Relapse,1105.0,Dead,1836.0,2007,2012.0,"ANBL00B1, ADVL0921, ANBL1021",Stage 4,Not Amplified,Diploid (DI=1),1.0,Unfavorable,Undifferentiated or Poorly Differentiated,Low,Neuroblastoma,C47.3,Peripheral nerves and Autonomic nervous system of thorax  Peripheral nerves and Autonomic nervous system of (see list under C47):  . Axilla  . Chest  . chest wall  . thoracic wall  . infraclavicular region  . scapular region  Intercostal nerve,High Risk,90,40,90/10,,Bone,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,301b4e88-545d-4c7e-9422-7faa968942fd.htseq.counts,test_version148_GeneExpressionCounts,2f9ba82e-7d19-49ed-a52c-266628aa834f,1273709,2f9ba82e-7d19-49ed-a52c-266628aa834f,2017-10-06T08:32:53.477865-05:00,a859e5741ea8c61bbb6a1f82a69f6929,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,5698c72b-45d7-55fc-a52d-8082f26471ac,af7249ba-9ef1-57e3-a685-47c7296faf7b,TARGET-30-PARFWB-01A-01R,aliquot
77,TARGET-30-PARGKK,Male,Black or African American,Not Hispanic or Latino,2241,Progression,1075.0,Dead,1321.0,2007,2011.0,"ANBL00B1, ADVL0812",Stage 4,Not Amplified,Diploid (DI=1),1.0,Unfavorable,Differentiating,Low,Neuroblastoma,C76.2,"Abdomen, NOS  Abdominal wall, NOS  Intra-abdominal site, NOS",High Risk,40,10,40/60,,Bone,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,4a946572-ad2c-4759-baf4-0a8cbe3ed5df.htseq.counts,test_version77_GeneExpressionCounts,03ae150d-02e7-4246-8d59-c558d28fc2c6,1271029,03ae150d-02e7-4246-8d59-c558d28fc2c6,2017-10-06T08:27:34.954478-05:00,27e939e40b74c665b20328c3208c0919,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,1cfada7f-552d-5081-8da8-f748211b8c4e,ec0f13c9-dd39-5eb2-ad44-2e07ce0cb634,TARGET-30-PARGKK-01A-01R,aliquot
78,TARGET-30-PARHAM,Female,White,Not Hispanic or Latino,341,Progression,38.0,Dead,2466.0,2007,2014.0,ANBL00B1,Stage 4,Not Amplified,Hyperdiploid (DI>1),1.23,Favorable,Unknown,Unknown,Neuroblastoma,C76.3," Pelvis, NOS

Buttock, NOS

Groin, NOS

Ischiorectal fossa

P",Intermediate Risk,90,10,90/10,,Primary Site,95,3.0,,hyperdiploid miscoded as diploid/hypodiploid in previous update,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,af82838c-9071-4dd7-8766-b818cf61cf82.htseq.counts,test_version143_GeneExpressionCounts,b7236608-cb39-4eb6-b876-aa8369471d4f,1266491,b7236608-cb39-4eb6-b876-aa8369471d4f,2017-10-06T08:32:30.320255-05:00,2af0bdc50602e23ddbfb677ed2ba5faf,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,f6642ab2-9db3-5606-8487-25da917a06eb,7f40cb61-c0d6-565f-8a8e-6af8923e1355,TARGET-30-PARHAM-02A-01R,aliquot
79,TARGET-30-PARHAM,Female,White,Not Hispanic or Latino,341,Progression,38.0,Dead,2466.0,2007,2014.0,ANBL00B1,Stage 4,Not Amplified,Hyperdiploid (DI>1),1.23,Favorable,Unknown,Unknown,Neuroblastoma,C76.3," Pelvis, NOS

Buttock, NOS

Groin, NOS

Ischiorectal fossa

P",Intermediate Risk,90,10,90/10,,Primary Site,95,3.0,,hyperdiploid miscoded as diploid/hypodiploid in previous update,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,ec63aa87-9456-416b-9f74-a2b25e80b2c2.htseq.counts,test_version68_GeneExpressionCounts,ed12aeb6-8db1-4623-83ea-754d18bce6cd,1273052,ed12aeb6-8db1-4623-83ea-754d18bce6cd,2017-10-06T08:26:46.721146-05:00,8fbb0c6373d6bf0f03c2e5998a965b3c,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,0451facc-e97f-55e3-a166-c6ce379b2d05,7f40cb61-c0d6-565f-8a8e-6af8923e1355,TARGET-30-PARHAM-01A-01R,aliquot
80,TARGET-30-PARJVP,Male,Unknown,Not Hispanic or Latino,56,Censored,2064.0,Alive,2064.0,2007,2013.0,ANBL00B1,Stage 4s,Not Amplified,Hyperdiploid (DI>1),2.04,Favorable,Undifferentiated or Poorly Differentiated,Unknown,Neuroblastoma,C74.9," Adrenal gland, NOS

Suprarenal gland

Adrenal, NOS",Low Risk,90,10,90/10,,,,,,hyperdiploid miscoded as diploid/hypodiploid in previous update,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,4e4df7f7-121f-4237-9611-ad11e64ac1de.htseq.counts,test_version36_GeneExpressionCounts,b35a74b2-1d85-4609-8b38-5f55a7322a85,1272898,b35a74b2-1d85-4609-8b38-5f55a7322a85,2017-10-06T08:24:28.919403-05:00,dfd75b9c79157848b0f0e0f1424182c0,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,7dfad7d5-a1aa-592c-a868-ce669ec3a060,9e6e1f97-1ecc-5a48-af09-52f27d8b0692,TARGET-30-PARJVP-01A-01R,aliquot
81,TARGET-30-PARKGJ,Male,White,Not Hispanic or Latino,1616,Relapse,841.0,Dead,1636.0,2007,2012.0,ANBL00B1,Stage 4,Not Amplified,Hyperdiploid (DI>1),1.12,Unfavorable,Undifferentiated or Poorly Differentiated,High,Neuroblastoma,C42.1,Bone marrow,High Risk,80,90,80/20,,"Other, specify: Increased VMA/HVA since 9-09.CT Pelvic 12/9/09 New low attenuation lesion rt. lobe of liver, maybe additional liver lesion within rt.lobe. Hepatic lesions are now detected and there is developing abnormal soft tissue rt side retroperitoneum & ill definition & stranding throughout rt psoas & iliacus muscle.",,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,87c94a89-6345-4079-9e0d-17a91d6a96ed.htseq.counts,test_version70_GeneExpressionCounts,83772960-4d13-4142-8b3d-263a10fc1fd3,1270331,83772960-4d13-4142-8b3d-263a10fc1fd3,2017-10-06T08:27:10.511052-05:00,62a64e46a2b9930925c3f115972c9c56,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,d72fbb69-a1b7-522b-9f79-35b8475e4bc2,494b9079-9646-5112-8b16-a9e5c4c6bcf5,TARGET-30-PARKGJ-01A-01R,aliquot
82,TARGET-30-PARNNC,Female,White,Not Hispanic or Latino,41,Relapse,735.0,Alive,2611.0,2007,2014.0,ANBL00B1,Stage 4s,Not Amplified,Hyperdiploid (DI>1),1.31,Favorable,Undifferentiated or Poorly Differentiated,Low,Neuroblastoma,C48.0," Retroperitoneum

Periadrenal tissue

Perinephric tissue

Per",Low Risk,10-20,10,10-20/80-90,,Primary site; Other metastatic sites,,,,hyperdiploid miscoded as diploid/hypodiploid in previous update,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,8c78ab0d-7e08-4518-94d3-dca147c8bb97.htseq.counts,test_version150_GeneExpressionCounts,1ef3c255-e94a-4ed4-86b0-a55661a9a884,1274640,1ef3c255-e94a-4ed4-86b0-a55661a9a884,2017-10-06T08:33:16.304824-05:00,ae392455cae62a2dd2967687d30bb77d,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,ba092e12-d36d-5ca9-af5f-ca0c65c188fd,53a0d60e-66fa-5def-9f05-6e989ed754aa,TARGET-30-PARNNC-01A-01R,aliquot
83,TARGET-30-PARSBI,Female,White,Not Hispanic or Latino,2390,Relapse,1377.0,Dead,1743.0,2007,2012.0,"ANBL00B1, ADVL0921, ANBL1021",Stage 4,Not Amplified,Hyperdiploid (DI>1),1.4,Unfavorable,Undifferentiated or Poorly Differentiated,Low,Neuroblastoma,C76.2,"Abdomen, NOS  Abdominal wall, NOS  Intra-abdominal site, NOS",High Risk,90,90,90/10,,Other metastatic sites,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,b7fd0fc8-a27d-46d6-a782-d5b624aa81fe.htseq.counts,test_version69_GeneExpressionCounts,2c5c6668-9ff0-4a1e-a89b-013f5f515dcf,1273232,2c5c6668-9ff0-4a1e-a89b-013f5f515dcf,2017-10-06T08:26:46.721146-05:00,81f5476901013e9d476056784a51c317,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,fc85f73f-e8c9-51a2-82c9-4fca53172f31,aff28966-3ffe-552a-be60-791e4be13497,TARGET-30-PARSBI-01A-01R,aliquot
84,TARGET-30-PARVLK,Female,White,Hispanic or Latino,6021,Event,428.0,Dead,875.0,2008,2010.0,ANBL00B1,Stage 4,Not Amplified,Hyperdiploid (DI>1),1.15,Unknown,Unknown,Unknown,"Ganglioneuroblastoma, intermixed",C74.9,"Adrenal gland, NOS  Suprarenal gland  Adrenal, NOS",High Risk,70,10,70/30,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,9fd943be-b3d4-4fc1-8f22-69edf84f1871.htseq.counts,test_version31_GeneExpressionCounts,28be129b-f449-4b46-81ba-7fef28d0d4b3,1267461,28be129b-f449-4b46-81ba-7fef28d0d4b3,2017-10-06T08:24:05.575877-05:00,42f0865824cf4bb86515fb6c816e0192,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,941edf9d-b6ab-5a49-9691-03b797217b1b,989d9366-d75a-5ea2-92b7-f787cbd4c5cd,TARGET-30-PARVLK-01A-01R,aliquot
85,TARGET-30-PARYNK,Female,White,Hispanic or Latino,2279,Censored,2351.0,Alive,2351.0,2008,2014.0,"ANBL00B1, ANBL0532",Stage 4,Not Amplified,Diploid (DI=1),1.0,Unfavorable,Undifferentiated or Poorly Differentiated,Intermediate,Neuroblastoma,C77.2,Intra-abdominal lymph nodes Abdominal lymph node Aortic lymph node Celiac lymph node Colic lymph node Common duct lymph node Gastric lymph node Hepatic lymph node Ileocolic lymph node Inferior mesenteric lymph node Intestinal lymph node Lumbar lymph node,High Risk,90,10-15,90/10,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,6ae8bc40-ca9f-4b71-a809-4d70396b116a.htseq.counts,test_version42_GeneExpressionCounts,36411c9d-30c2-443c-a802-0dcd35782882,1273003,36411c9d-30c2-443c-a802-0dcd35782882,2017-10-06T08:24:52.252607-05:00,8dadff7e5ebe31c99ee4a52d15d18ed5,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,d41a646e-edd9-5440-a106-23a18bad5fc8,117e4e39-d43d-5d08-be3e-9bd8c1e5d5e5,TARGET-30-PARYNK-01A-01R,aliquot
86,TARGET-30-PARZCJ,Male,White,Not Hispanic or Latino,242,Censored,2435.0,Alive,2435.0,2008,2015.0,"ANBL00B1, ANBL0531, AEPI07N1",Stage 3,Not Amplified,Hyperdiploid (DI>1),1.54,Favorable,Undifferentiated or Poorly Differentiated,Low,Neuroblastoma,C74.9," Adrenal gland, NOS

Suprarenal gland

Adrenal, NOS",Intermediate Risk,70,15-20,70/30,,,50-95,0.0,,hyperdiploid miscoded as diploid/hypodiploid in previous update,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,4a4870d5-d6ef-4edc-ada0-6183752b8b14.htseq.counts,test_version87_GeneExpressionCounts,da9a0171-aad6-418e-91fe-c8af7babca53,1272845,da9a0171-aad6-418e-91fe-c8af7babca53,2017-10-06T08:28:17.762914-05:00,199109550002d0acbc07eb3226cd2edc,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,c7465eb4-bce7-56ae-adcf-822cd81dbedc,b43dfc79-e12b-5488-8cd2-dd29abb515c6,TARGET-30-PARZCJ-01A-01R,aliquot
87,TARGET-30-PARZHA,Male,Unknown,Unknown,3,Censored,2489.0,Alive,2489.0,2008,2015.0,ANBL00B1,Stage 4s,Not Amplified,Hyperdiploid (DI>1),1.21,Favorable,Undifferentiated or Poorly Differentiated,Low,Neuroblastoma,C48.0," Retroperitoneum

Periadrenal tissue

Perinephric tissue

Per",Low Risk,90,,,,,,,,hyperdiploid miscoded as diploid/hypodiploid in previous update,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,0d9a80ce-b0f2-4c57-b4a9-14ed3ac7b31e.htseq.counts,test_version96_GeneExpressionCounts,ac05f0e1-be8f-4c7f-827c-e4a443f4d856,1271341,ac05f0e1-be8f-4c7f-827c-e4a443f4d856,2017-10-06T08:29:01.889718-05:00,405cecbddaf75e00805b27aa0ad58f06,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,768baffa-3b83-54a2-baae-c1c8d751b5e1,fc9d5f9e-af43-5134-95e7-2d434831580b,TARGET-30-PARZHA-01A-01R,aliquot
88,TARGET-30-PARZIP,Male,Unknown,Unknown,2273,Relapse,632.0,Alive,2511.0,2008,2015.0,"ANBL00B1, ANBL0532, ANBL0032",Stage 4,Not Amplified,Hyperdiploid (DI>1),1.45,Unfavorable,Undifferentiated or Poorly Differentiated,Low,Neuroblastoma,C64.9,"Kidney, NOS  Renal, NOS  Kidney parenchyma",High Risk,80,20,80/20,,Bone Proximal left femur,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,887df144-5092-434f-bb48-cc0ab0ab77ec.htseq.counts,test_version130_GeneExpressionCounts,297aa29f-b08a-4e40-978b-2c2e7c378b01,1275932,297aa29f-b08a-4e40-978b-2c2e7c378b01,2017-10-06T08:31:43.284163-05:00,bd73fde53141ea0cea17e1444ab21c3c,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,dc10b859-6c41-52f6-bd14-01cdb4c16552,0a6bb83b-d210-5894-8268-bdc74e6d4be2,TARGET-30-PARZIP-01A-01R,aliquot
89,TARGET-30-PASCFC,Male,White,Not Hispanic or Latino,18,Censored,2522.0,Alive,2522.0,2008,2015.0,ANBL00B1,Stage 4s,Not Amplified,Hyperdiploid (DI>1),2.36,Favorable,Undifferentiated or Poorly Differentiated,Low,Neuroblastoma,C74.9," Adrenal gland, NOS

Suprarenal gland

Adrenal, NOS",Low Risk,75,,,,,,,,hyperdiploid miscoded as diploid/hypodiploid in previous update,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,c2be6c07-fb29-4f17-8c3a-6327f4ec3235.htseq.counts,test_version125_GeneExpressionCounts,5a046111-c6fe-4d09-a6d3-66d4d99410d3,1273270,5a046111-c6fe-4d09-a6d3-66d4d99410d3,2017-10-06T08:31:18.033493-05:00,93e0f49b2ca989af71101354e9605595,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,10b086c3-1bc2-58c8-b7b6-0854ca184779,439e55c7-b552-5d53-b14d-2d1433b0b3f1,TARGET-30-PASCFC-01A-01R,aliquot
90,TARGET-30-PASCTR,Male,White,Not Hispanic or Latino,60,Censored,2325.0,Alive,2325.0,2008,2014.0,"ANBL00B1, ANBL0531",Stage 4s,Not Amplified,Hyperdiploid (DI>1),1.97,Favorable,Undifferentiated or Poorly Differentiated,Low,Neuroblastoma,C74.0, Cortex of adrenal gland,Intermediate Risk,40,,,,,,,,hyperdiploid miscoded as diploid/hypodiploid in previous update,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,92fd610e-05fa-48ea-8127-42def9574406.htseq.counts,test_version50_GeneExpressionCounts,fff2056e-1e1c-4d91-88b0-37e04679aeb5,1272289,fff2056e-1e1c-4d91-88b0-37e04679aeb5,2017-10-06T08:25:37.569933-05:00,63f7c7c93e22857ad2a6f3970c790452,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,62cbf8aa-0d6d-5b6f-b126-45fdcc0a48ce,04e3b1e1-9069-5fff-b1fa-1977911d0950,TARGET-30-PASCTR-01A-01R,aliquot
91,TARGET-30-PASEGA,Male,White,Not Hispanic or Latino,1091,Progression,469.0,Dead,809.0,2008,2010.0,"ANBL00B1, ANBL0532, ANBL0032",Stage 4,Not Amplified,Diploid (DI=1),1.0,Unfavorable,Undifferentiated or Poorly Differentiated,High,"Ganglioneuroblastoma, nodular",C74.9,"Adrenal gland, NOS  Suprarenal gland  Adrenal, NOS",High Risk,70,10,70/30,,Liver; Lymph Nodes,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,afdcbe2a-e23f-43de-9bae-ed6e146333dd.htseq.counts,test_version131_GeneExpressionCounts,bd56f5f4-f319-4c06-9b84-1073aae81e5d,1276914,bd56f5f4-f319-4c06-9b84-1073aae81e5d,2017-10-06T08:31:43.284163-05:00,bc7659f04336de0843fd3c84a2b05687,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,4583a291-8566-526d-a2fb-ee88ed037cd6,b46dda45-a174-5730-ac8a-07b1995ab38b,TARGET-30-PASEGA-01A-01R,aliquot
92,TARGET-30-PASFGG,Female,White,Not Hispanic or Latino,1037,Death,700.0,Dead,700.0,2008,2010.0,ANBL00B1,Stage 4,Not Amplified,Hyperdiploid (DI>1),1.14,Unfavorable,Undifferentiated or Poorly Differentiated,High,Neuroblastoma,C76.2,"Abdomen, NOS  Abdominal wall, NOS  Intra-abdominal site, NOS",High Risk,60,10,60/40,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,f3d1dd95-37da-48be-88f2-0312bdc161d2.htseq.counts,test_version129_GeneExpressionCounts,ac069baa-07e2-4493-9d4c-ade21e3a25be,1276922,ac069baa-07e2-4493-9d4c-ade21e3a25be,2017-10-06T08:31:18.033493-05:00,17489dc2d772ec5e59ba6633d6838d70,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,c1c1ea01-2dd6-5e95-a19f-31bb58a9a7ba,27974517-47f9-5d3f-b011-62b88ad01d4b,TARGET-30-PASFGG-01A-01R,aliquot
93,TARGET-30-PASFIC,Male,White,Not Hispanic or Latino,51,Censored,2152.0,Alive,2152.0,2008,2014.0,"ANBL00B1, AEPI07N1",Stage 4s,Not Amplified,Hyperdiploid (DI>1),1.67,Favorable,Undifferentiated or Poorly Differentiated,Low,Neuroblastoma,C74.9," Adrenal gland, NOS

Suprarenal gland

Adrenal, NOS",Low Risk,80,,,,,,,,hyperdiploid miscoded as diploid/hypodiploid in previous update,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,d9a69f61-4a4e-4eb3-90f5-e486c646e006.htseq.counts,test_version142_GeneExpressionCounts,4c63a4aa-d246-44ce-afa8-27d5e20866e1,1273195,4c63a4aa-d246-44ce-afa8-27d5e20866e1,2017-10-06T08:32:30.320255-05:00,590aab8196ab7f57c2fbeb43d4ac2759,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,50e1577d-c114-58a4-a085-1f8dc9a11e56,f06cf3b2-e8ec-58e5-999c-0c199cae0cb4,TARGET-30-PASFIC-01A-01R,aliquot
94,TARGET-30-PASGAP,Male,Black or African American,Not Hispanic or Latino,1330,Progression,1285.0,Dead,1543.0,2008,2013.0,"ANBL00B1, ANBL0032",Stage 4,Not Amplified,Diploid (DI=1),1.0,Unfavorable,Undifferentiated or Poorly Differentiated,Low,"Ganglioneuroblastoma, nodular",C74.9," Adrenal gland, NOS
Suprarenal gland
Adrenal, NOS",High Risk,90,10,90/10,,"Bone; Other, specify: Bone and soft tissue of skull, occipital skull/epidural tumor.",65-96,1.0,71-100/0-29,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,ec70002f-5275-4abb-9054-c1e9b105fda3.htseq.counts,test_version12_GeneExpressionCounts,a28a6ff2-6cca-493e-8f3c-8944ba924d93,1265632,a28a6ff2-6cca-493e-8f3c-8944ba924d93,2017-10-06T08:22:37.905981-05:00,3f2ca3fd7ac60cd5fc834c35ecc5a681,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,d17ec10d-b97d-587b-a07c-59fb74860294,702ef394-91ad-5f18-b50a-7d0d3e8349fa,TARGET-30-PASGAP-02A-01R,aliquot
95,TARGET-30-PASGAP,Male,Black or African American,Not Hispanic or Latino,1330,Progression,1285.0,Dead,1543.0,2008,2013.0,"ANBL00B1, ANBL0032",Stage 4,Not Amplified,Diploid (DI=1),1.0,Unfavorable,Undifferentiated or Poorly Differentiated,Low,"Ganglioneuroblastoma, nodular",C74.9," Adrenal gland, NOS
Suprarenal gland
Adrenal, NOS",High Risk,90,10,90/10,,"Bone; Other, specify: Bone and soft tissue of skull, occipital skull/epidural tumor.",65-96,1.0,71-100/0-29,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,e3eabcbe-d0e8-42a2-8533-2abbfcb84b20.htseq.counts,test_version151_GeneExpressionCounts,536cd03b-0bc8-4b86-8535-5b1edde385aa,1270445,536cd03b-0bc8-4b86-8535-5b1edde385aa,2017-10-06T08:33:16.304824-05:00,e1ffcc4771146d473da5ba09c8e594e9,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,c109a713-bf18-5316-84fe-d89acf314e99,702ef394-91ad-5f18-b50a-7d0d3e8349fa,TARGET-30-PASGAP-01A-01R,aliquot
96,TARGET-30-PASGUT,Male,White,Hispanic or Latino,1259,Censored,401.0,Alive,401.0,2008,2009.0,ANBL00B1,Stage 4,Not Amplified,Diploid (DI=1),1.0,Unfavorable,Undifferentiated or Poorly Differentiated,Low,"Ganglioneuroblastoma, nodular",C74.9,"Adrenal gland, NOS  Suprarenal gland  Adrenal, NOS",High Risk,90,10,90/10,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,ea7294a2-0b3b-41a8-82db-5988039ee9fc.htseq.counts,test_version108_GeneExpressionCounts,aef553f5-0c79-434d-a0ea-f3a3f903471f,1277881,aef553f5-0c79-434d-a0ea-f3a3f903471f,2017-10-06T08:29:48.873012-05:00,f731d498d2ea6f49f59568c7178434b6,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,3149474e-b441-55af-84c9-3bddf601dee6,635c1f86-a369-59cb-811c-172bcb660eb6,TARGET-30-PASGUT-01A-01R,aliquot
97,TARGET-30-PASHFA,Female,White,Not Hispanic or Latino,406,Progression,201.0,Dead,333.0,2008,2009.0,"ANBL00B1, ANBL0531, ANBL0532",Stage 3,Amplified,Diploid (DI=1),1.0,Unfavorable,Undifferentiated or Poorly Differentiated,High,Neuroblastoma,C74.9," Adrenal gland, NOS

Suprarenal gland

Adrenal, NOS",High Risk,60,10,60/40,,Primary site,98-99,10.0,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,8ec5dd32-aab9-4c78-a5c2-dc9e0d55af65.htseq.counts,test_version103_GeneExpressionCounts,9b7a55c1-c8ca-46cd-a221-63b951aa01d8,1269087,9b7a55c1-c8ca-46cd-a221-63b951aa01d8,2017-10-06T08:29:25.488029-05:00,f01af884d6a9fee5873ea15ada0ef6d9,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,976a9770-7adf-5ce4-915c-6f7cffcc272e,1ca6f540-5926-5516-9347-7b9fa3b93ed4,TARGET-30-PASHFA-01A-01R,aliquot
98,TARGET-30-PASJZC,Female,White,Not Hispanic or Latino,74,Relapse,367.0,Alive,2083.0,2009,2014.0,ANBL00B1,Stage 4s,Amplified,Hyperdiploid (DI>1),1.45,Favorable,Undifferentiated or Poorly Differentiated,Low,Neuroblastoma,C22.0," Liver

Hepatic, NOS",High Risk,55,,,,Primary site,,,,hyperdiploid miscoded as diploid/hypodiploid in previous update,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,7c1a8c9e-0e38-4344-b79e-73aceb75489a.htseq.counts,test_version47_GeneExpressionCounts,465cda40-5705-4059-89b7-be7b3c736b3f,1277479,465cda40-5705-4059-89b7-be7b3c736b3f,2017-10-06T08:25:15.152144-05:00,0c4fbdcdc10b4ef31d9c7956a349af86,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,b1b78812-0936-501a-a436-a8252d953091,717c4844-5ef9-553b-bb90-0d62d976f909,TARGET-30-PASJZC-01A-01R,aliquot
99,TARGET-30-PASMDM,Male,White,Not Hispanic or Latino,25,Censored,1324.0,Alive,1324.0,2009,2012.0,ANBL00B1,Stage 4s,Not Amplified,Hyperdiploid (DI>1),2.27,Favorable,Undifferentiated or Poorly Differentiated,Low,Neuroblastoma,C74.9," Adrenal gland, NOS

Suprarenal gland

Adrenal, NOS",Low Risk,40,10,40/60,,,,,,hyperdiploid miscoded as diploid/hypodiploid in previous update,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,a0c20437-5cbd-47f2-a635-9466a8d61c25.htseq.counts,test_version92_GeneExpressionCounts,776db67a-ddc4-4488-9406-9e961048f8bf,1273801,776db67a-ddc4-4488-9406-9e961048f8bf,2017-10-06T08:28:39.214953-05:00,c04c2605e544f692038b7153b486bf80,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,45a07950-2b7b-551f-a82e-86fcf42467f2,78414b12-19e4-5e7e-b564-a3d9fdcc28e3,TARGET-30-PASMDM-01A-01R,aliquot
100,TARGET-30-PASMJG,Female,Not Reported,Not Hispanic or Latino,1765,Progression,1162.0,Dead,1544.0,2009,2013.0,"ANBL00B1, ANBL0032",Stage 4,Not Amplified,Diploid (DI=1),1.0,Unfavorable,Undifferentiated or Poorly Differentiated,Unknown,"Ganglioneuroblastoma, nodular",C74.9,"Adrenal gland, NOS  Suprarenal gland  Adrenal, NOS",High Risk,90,10,90/10,,Bone,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,305357aa-30a7-458f-a023-ede757d64591.htseq.counts,test_version158_GeneExpressionCounts,27e5c514-9c17-4279-9980-3da544a662a6,1274328,27e5c514-9c17-4279-9980-3da544a662a6,2017-10-06T08:33:38.856860-05:00,ce34c0ce8b2659ecfa8a1141c57fe1c1,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,663e87d8-12ef-50fd-9389-5cccfdc947aa,cb31a097-f6f5-53e7-8718-74d708b516fe,TARGET-30-PASMJG-01A-01R,aliquot
101,TARGET-30-PASMNT,Female,Native Hawaiian or other Pacific Islander,Not Hispanic or Latino,4802,Progression,233.0,Dead,1696.0,2009,2013.0,"ANBL00B1, ANBL0532",Stage 4,Not Amplified,Hyperdiploid (DI>1),1.1,Unfavorable,Undifferentiated or Poorly Differentiated,Intermediate,Neuroblastoma,C76.2,"Abdomen, NOS  Abdominal wall, NOS  Intra-abdominal site, NOS",High Risk,85,10,85/15,,Metastases only,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,ac395ca9-205e-45fd-89c1-d7676306e624.htseq.counts,test_version107_GeneExpressionCounts,c826b814-031e-416c-a7c6-5aefba1c0170,1275481,c826b814-031e-416c-a7c6-5aefba1c0170,2017-10-06T08:29:48.873012-05:00,d7422875c11d08ae5ec0e0b8bba8ef0a,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,1433c202-4b1b-56ab-83e0-a48bed790ef3,f69e76d0-cf58-57b1-9037-78b6c4f5857e,TARGET-30-PASMNT-01A-01R,aliquot
102,TARGET-30-PASNEF,Female,Not Reported,Hispanic or Latino,696,Censored,2213.0,Alive,2213.0,2009,2015.0,ANBL00B1,Stage 4,Not Amplified,Hyperdiploid (DI>1),1.97,Unfavorable,Undifferentiated or Poorly Differentiated,Intermediate,Neuroblastoma,C48.0,Retroperitoneum  Periadrenal tissue  Perinephric tissue  Peripancreatic tissue  Perirenal tissue  Retrocecal tissue  Retroperitoneal tissue,High Risk,85,25,85/15,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,8fe7274c-9053-40a1-8b2d-7e125195a28d.htseq.counts,test_version0_GeneExpressionCounts,3eb73d0f-3b8f-474d-9fa7-42d18e5ce6cf,1266428,3eb73d0f-3b8f-474d-9fa7-42d18e5ce6cf,2017-10-06T08:21:49.750654-05:00,29e7aedec6934d07072cdd257222393e,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,6a7d9058-3531-5cae-a143-6fa4e0cbefa0,d369ae2c-bcaf-5f19-a5f1-553db4738cef,TARGET-30-PASNEF-01A-01R,aliquot
103,TARGET-30-PASNML,Male,Not Reported,Not Hispanic or Latino,8,Censored,2185.0,Alive,2185.0,2009,2015.0,ANBL00B1,Stage 4s,Not Amplified,Hyperdiploid (DI>1),1.28,Favorable,Undifferentiated or Poorly Differentiated,Intermediate,Neuroblastoma,C38.3," Mediastinum, NOS",Low Risk,90,,,,,,,,hyperdiploid miscoded as diploid/hypodiploid in previous update,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,95b94a40-d6dc-4dba-9f35-f7b0e983bd40.htseq.counts,test_version86_GeneExpressionCounts,b7e1d1e4-44ea-4835-a79c-3403ee2497de,1271991,b7e1d1e4-44ea-4835-a79c-3403ee2497de,2017-10-06T08:28:17.762914-05:00,855a0fd4d015f1d8d2b0fc43a4c8d8d8,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,4f71979f-6506-5609-aa3f-8e7737f60e5b,2d79e5c4-ff25-5666-9faa-1097b3a6b7a4,TARGET-30-PASNML-01A-01R,aliquot
104,TARGET-30-PASNPG,Female,Black or African American,Not Hispanic or Latino,318,Event,302.0,Alive,2274.0,2009,2015.0,"ANBL00B1, ANBL0531",Stage 3,Not Amplified,Hyperdiploid (DI>1),1.48,Favorable,Undifferentiated or Poorly Differentiated,Intermediate,Neuroblastoma,C76.7," Other ill-defined sites

Back, NOS

Flank, NOS

Trunk, NOS",Intermediate Risk,90,10,90/10,,,75-90,10.0,,hyperdiploid miscoded as diploid/hypodiploid in previous update,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,84f91861-c750-4bed-94b3-834a91018aba.htseq.counts,test_version20_GeneExpressionCounts,5ae10576-5bf7-41fb-a855-5feb3c7069c3,1263223,5ae10576-5bf7-41fb-a855-5feb3c7069c3,2017-10-06T08:23:20.625172-05:00,615f859e638db7b6c76d14ddb61dbb91,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,066d3084-a3fc-52ee-84c8-0d1156c026e6,d8f6075b-844b-5cd1-a113-4cff018a831b,TARGET-30-PASNPG-02A-01R,aliquot
105,TARGET-30-PASNPG,Female,Black or African American,Not Hispanic or Latino,318,Event,302.0,Alive,2274.0,2009,2015.0,"ANBL00B1, ANBL0531",Stage 3,Not Amplified,Hyperdiploid (DI>1),1.48,Favorable,Undifferentiated or Poorly Differentiated,Intermediate,Neuroblastoma,C76.7," Other ill-defined sites

Back, NOS

Flank, NOS

Trunk, NOS",Intermediate Risk,90,10,90/10,,,75-90,10.0,,hyperdiploid miscoded as diploid/hypodiploid in previous update,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,2546775a-bcc8-4983-ae23-f03491e3a27d.htseq.counts,test_version54_GeneExpressionCounts,8572fe7d-e4a5-4fe3-8632-c5c5846aa804,1271596,8572fe7d-e4a5-4fe3-8632-c5c5846aa804,2017-10-06T08:25:37.569933-05:00,b7693862ebd5aaa3b231310ce274a621,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,ef5331ca-58a7-587e-8e7a-4f0503ec4de4,d8f6075b-844b-5cd1-a113-4cff018a831b,TARGET-30-PASNPG-01A-01R,aliquot
106,TARGET-30-PASNZU,Male,Black or African American,Not Hispanic or Latino,1099,Relapse,954.0,Dead,1692.0,2009,2013.0,"ANBL00B1, ANBL0532, ANBL0032, ACCL0934, ANBL1021",Stage 4,Amplified,Diploid (DI=1),1.0,Unfavorable,Undifferentiated or Poorly Differentiated,High,Neuroblastoma,C76.2,"Abdomen, NOS  Abdominal wall, NOS  Intra-abdominal site, NOS",High Risk,90,20,90/10,,"Other, specify: Right mandible soft tissue",,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,7c2b0108-1231-4543-a8bf-eb6644e76f41.htseq.counts,test_version97_GeneExpressionCounts,42f845a0-e2ce-4724-b405-c8978215c2e8,1273815,42f845a0-e2ce-4724-b405-c8978215c2e8,2017-10-06T08:29:01.889718-05:00,495e33dc678e5ad55d91839c344b1e55,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,a735ac4c-4566-58fb-896f-6fd4506ca26f,702fe27a-f55d-59f0-b838-d8fe9a9fc3ce,TARGET-30-PASNZU-01A-01R,aliquot
107,TARGET-30-PASPBZ,Male,Black or African American,Not Hispanic or Latino,62,Censored,2347.0,Alive,2347.0,2009,2015.0,"ANBL00B1, ANBL0531",Stage 4s,Not Amplified,Diploid (DI=1),1.0,Unfavorable,Undifferentiated or Poorly Differentiated,High,Neuroblastoma,C76.2," Abdomen, NOS

Abdominal wall, NOS

Intra-abdominal site, NOS",Intermediate Risk,80,,,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,d153c7a0-df42-4e61-81b9-2e72467c0ed7.htseq.counts,test_version104_GeneExpressionCounts,15270fb4-8f4e-4a26-a391-7d42576c46bb,1272324,15270fb4-8f4e-4a26-a391-7d42576c46bb,2017-10-06T08:29:25.488029-05:00,7a22a6d962603edc934ba49c4f084193,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,12fbd14e-25a0-5a79-8276-af41ca5c7826,4d0b779e-2e2f-5fe8-8a53-0992dcc29054,TARGET-30-PASPBZ-01A-01R,aliquot
108,TARGET-30-PASPER,Female,White,Hispanic or Latino,753,Progression,638.0,Alive,2087.0,2009,2014.0,"ANBL00B1, ANBL0032",Stage 4,Not Amplified,Diploid (DI=1),1.0,Unfavorable,Undifferentiated or Poorly Differentiated,Low,Neuroblastoma,C48.0,Retroperitoneum  Periadrenal tissue  Perinephric tissue  Peripancreatic tissue  Perirenal tissue  Retrocecal tissue  Retroperitoneal tissue,High Risk,90,10,90/10,,Bone,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,4194ec92-38f7-4449-b698-95da75eae017.htseq.counts,test_version124_GeneExpressionCounts,9a7c710d-b0ec-4785-befa-7397a9626c73,1278975,9a7c710d-b0ec-4785-befa-7397a9626c73,2017-10-06T08:30:54.984868-05:00,de4b8d47884ff15e0ab66ce77a1decf6,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,a83e05c1-4f92-56bc-a4fc-e5670b055259,7752cdb0-d157-5faf-8b3e-a72b5d077f3b,TARGET-30-PASPER-01A-01R,aliquot
109,TARGET-30-PASRFS,Female,White,Not Hispanic or Latino,1328,Relapse,1675.0,Alive,2075.0,2009,2014.0,"ANBL00B1, ANBL0032",Stage 4,Not Amplified,Diploid (DI=1),1.0,Unfavorable,Undifferentiated or Poorly Differentiated,Intermediate,Neuroblastoma,C76.2,"Abdomen, NOS  Abdominal wall, NOS  Intra-abdominal site, NOS",High Risk,70,10,70/30,,Bone,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,61b147dc-a769-42be-86c1-57b6ecf119ac.htseq.counts,test_version62_GeneExpressionCounts,1b1975cc-db84-4c82-9f54-24e0876bf202,1276709,1b1975cc-db84-4c82-9f54-24e0876bf202,2017-10-06T08:26:21.324309-05:00,799b7444dcd2805e7be95608442895f5,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,90b1ce8c-31e6-55de-9409-1fa70a5180d0,aad1677e-c4ab-5599-bffe-9b7eeebc7d22,TARGET-30-PASRFS-01A-01R,aliquot
110,TARGET-30-PASSRN,Male,White,Not Hispanic or Latino,5345,Censored,2227.0,Alive,2227.0,2009,2015.0,"ANBL00B1, ANBL0532, ANBL0931",Stage 4,Amplified,Hyperdiploid (DI>1),1.11,Unfavorable,Undifferentiated or Poorly Differentiated,Low,Neuroblastoma,C74.9,"Adrenal gland, NOS  Suprarenal gland  Adrenal, NOS",High Risk,35,5,35/65,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,e516732d-caf8-40f4-aa2a-2d250c7ce5b1.htseq.counts,test_version26_GeneExpressionCounts,f904505e-11d2-4ef0-8f14-7154a2f5d853,1265568,f904505e-11d2-4ef0-8f14-7154a2f5d853,2017-10-06T08:23:42.670826-05:00,e61613073b5b9e2a4a7676c551016ceb,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,16da098d-7f0f-5b8d-9a20-cec2f4fb1307,6904a582-7556-5299-9dd8-c997fa4b9a98,TARGET-30-PASSRN-01A-01R,aliquot
111,TARGET-30-PASSRS,Male,Unknown,Not Hispanic or Latino,2492,Relapse,861.0,Dead,1319.0,2009,2012.0,"ANBL00B1, ANBL0532, ANBL0032, ADVL0912, ANBL1021",Stage 4,Not Amplified,Hyperdiploid (DI>1),1.82,Unfavorable,Undifferentiated or Poorly Differentiated,Intermediate,Neuroblastoma,C76.2,"Abdomen, NOS  Abdominal wall, NOS  Intra-abdominal site, NOS",High Risk,65,15,65/35,,Bone,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,b62a4938-b6e7-4b5b-8033-9ae0d0893afd.htseq.counts,test_version57_GeneExpressionCounts,4bdfc4e9-2a42-49af-975d-855601d25bd6,1274937,4bdfc4e9-2a42-49af-975d-855601d25bd6,2017-10-06T08:25:57.903017-05:00,0a1a436679652c88e7be7d627faf2deb,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,2642f7cb-3263-5b5d-ae8d-9c3aae3d499e,2f1a64ad-f106-5c4e-9596-6cf0d22e83ae,TARGET-30-PASSRS-01A-01R,aliquot
112,TARGET-30-PASSWW,Male,White,Not Hispanic or Latino,7,Censored,2095.0,Alive,2095.0,2009,2015.0,"ANBL00B1, ANBL0531, AEPI07N1",Stage 4s,Not Amplified,Diploid (DI=1),1.0,Favorable,Undifferentiated or Poorly Differentiated,Low,Neuroblastoma,C64.9," Kidney, NOS

Renal, NOS

Kidney parenchyma",Intermediate Risk,90,20,90/10,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,925151ab-0679-43a4-808f-2e4237cfd7fc.htseq.counts,test_version17_GeneExpressionCounts,ec2d9440-bcf7-446a-a563-d2d4bb37e8a6,1271922,ec2d9440-bcf7-446a-a563-d2d4bb37e8a6,2017-10-06T08:23:00.878915-05:00,ff8c83b9fff842b0a8599d94a6e0672d,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,092c8f95-e86b-55bd-ae48-680023bd6792,062d487b-0fc6-56a9-8e05-615faa146e07,TARGET-30-PASSWW-01A-01R,aliquot
113,TARGET-30-PASTCN,Male,White,Not Hispanic or Latino,1900,Relapse,870.0,Dead,1033.0,2009,2012.0,"ANBL00B1, ANBL0532",Stage 4,Not Amplified,Diploid (DI=1),1.0,Unfavorable,Undifferentiated or Poorly Differentiated,Intermediate,Neuroblastoma,C48.8,Overlapping lesion of retroperitoneum and peritoneum  (See note page 1),High Risk,50,10,50/50,,Local (at site of primary),,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,13cdd61f-3aae-46cc-beae-af27862ab950.htseq.counts,test_version35_GeneExpressionCounts,d04be5e5-9c8e-46b2-9b7c-0de0b88bc2ea,1274900,d04be5e5-9c8e-46b2-9b7c-0de0b88bc2ea,2017-10-06T08:24:28.919403-05:00,57b281795909a3a3207e59c14b22b4c7,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,4aae0815-d0e2-5fa4-803f-397ee0148930,33fd4c17-55cd-5ab0-83c7-a6ef04a6c8b8,TARGET-30-PASTCN-01A-01R,aliquot
114,TARGET-30-PASTKC,Male,White,Not Hispanic or Latino,3035,Censored,1952.0,Alive,1952.0,2009,2014.0,"ANBL00B1, ANBL0532, ANBL0032",Stage 4,Not Amplified,Hyperdiploid (DI>1),1.14,Unfavorable,Undifferentiated or Poorly Differentiated,Low,Neuroblastoma,C76.2,"Abdomen, NOS  Abdominal wall, NOS  Intra-abdominal site, NOS",High Risk,30-40,10,30-40/60-70,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,8bd4f593-7cab-42f0-b604-044442bb661e.htseq.counts,test_version13_GeneExpressionCounts,82a86f37-1b62-4485-9f86-1fa3a5e51f0b,1273748,82a86f37-1b62-4485-9f86-1fa3a5e51f0b,2017-10-06T08:22:37.905981-05:00,73fd9b8e8bc0e4d5de58bd7b42324265,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,7629ad1a-cb6e-572b-b6a7-02b874bf785b,b1e099d5-1f38-5ead-a836-acc4bed69eea,TARGET-30-PASTKC-01A-01R,aliquot
115,TARGET-30-PASUCB,Male,White,Not Hispanic or Latino,1008,Censored,1976.0,Alive,1976.0,2009,2014.0,"ANBL00B1, ANBL0532, ANBL0032, AEPI07N1",Stage 4,Not Amplified,Diploid (DI=1),1.0,Unfavorable,Undifferentiated or Poorly Differentiated,Low,Neuroblastoma,C74.9,"Adrenal gland, NOS  Suprarenal gland  Adrenal, NOS",High Risk,90,10,90/10,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,6ea52dc5-77be-4a8d-8234-97d7800b44b3.htseq.counts,test_version120_GeneExpressionCounts,9caae20a-f218-4e52-af7e-70f57ff710e3,1275999,9caae20a-f218-4e52-af7e-70f57ff710e3,2017-10-06T08:30:54.984868-05:00,132383505408649e6e18beee26fad08b,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,5004ec3e-27c2-589d-bae9-5a1cfae90e5d,cef271f5-387a-5b43-be9f-4bfbee63ca91,TARGET-30-PASUCB-01A-01R,aliquot
116,TARGET-30-PASUYG,Male,Black or African American,Not Hispanic or Latino,1418,Relapse,505.0,Alive,2193.0,2009,2015.0,"ANBL00B1, ANBL0532, ANBL0032",Stage 4,Not Amplified,Hyperdiploid (DI>1),3.0,Unfavorable,Undifferentiated or Poorly Differentiated,Intermediate,Neuroblastoma,C74.9,"Adrenal gland, NOS  Suprarenal gland  Adrenal, NOS",High Risk,60,10,60/40,,Bone Marrow,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,733557c7-a67c-4e2e-92cc-a9b29d4eca3f.htseq.counts,test_version99_GeneExpressionCounts,0a21b137-a1dc-4f9f-a4fb-55e0800d7298,1268794,0a21b137-a1dc-4f9f-a4fb-55e0800d7298,2017-10-06T08:29:01.889718-05:00,e386ad55e527416398c992ce15ef734e,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,bccb936d-1a79-586c-8e5b-ef69ff70919d,1f0a8d57-806f-5813-a946-24a97f2794ad,TARGET-30-PASUYG-01A-01R,aliquot
117,TARGET-30-PASVRU,Male,White,Hispanic or Latino,631,Event,254.0,Dead,440.0,2009,2010.0,"ANBL00B1, ANBL0532",Stage 4,Amplified,Diploid (DI=1),1.0,Unfavorable,Undifferentiated or Poorly Differentiated,High,Neuroblastoma,C48.0,Retroperitoneum  Periadrenal tissue  Perinephric tissue  Peripancreatic tissue  Perirenal tissue  Retrocecal tissue  Retroperitoneal tissue,High Risk,80,10,80/20,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,86234da9-2f20-47a3-a2b6-44800328bdcf.htseq.counts,test_version65_GeneExpressionCounts,b2fc14b6-a281-4eb6-8186-82113f60c720,1267772,b2fc14b6-a281-4eb6-8186-82113f60c720,2017-10-06T08:26:46.721146-05:00,a825a2c4c178748dbab2ac3995842ec4,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,ad15700c-48a2-5aa9-8932-a9993bcfe5d5,0500d47a-3db5-5fcc-a92a-08955927b17d,TARGET-30-PASVRU-01A-01R,aliquot
118,TARGET-30-PASWFB,Female,Black or African American,Not Hispanic or Latino,727,Death,87.0,Dead,87.0,2009,2009.0,ANBL00B1,Stage 4,Amplified,Hyperdiploid (DI>1),1.8,Unfavorable,Undifferentiated or Poorly Differentiated,High,Neuroblastoma,C76.2,"Abdomen, NOS  Abdominal wall, NOS  Intra-abdominal site, NOS",High Risk,90,10,90/10,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,f510617c-68c6-4c99-b50b-589242906d1b.htseq.counts,test_version67_GeneExpressionCounts,d1aa6e66-70dd-4f7c-aacc-e2e7d4709693,1272505,d1aa6e66-70dd-4f7c-aacc-e2e7d4709693,2017-10-06T08:26:46.721146-05:00,56631507fd879f0e88ca05f21ab42d8e,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,65480c14-b975-550b-a2bd-7f87ebe7d63d,bcc81d85-779c-5501-be5a-0939068dec81,TARGET-30-PASWFB-01A-01R,aliquot
119,TARGET-30-PASWIJ,Male,White,Not Hispanic or Latino,2537,Censored,1940.0,Alive,1940.0,2009,2014.0,"ANBL00B1, ANBL0532, ANBL0931",Stage 4,Not Amplified,Hyperdiploid (DI>1),1.11,Unfavorable,Undifferentiated or Poorly Differentiated,Intermediate,Neuroblastoma,C76.2,"Abdomen, NOS  Abdominal wall, NOS  Intra-abdominal site, NOS",High Risk,80,5,80/20,,,,,,pt subsequently determined not to have had an event,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,01c87dd9-4a5d-4cdd-844d-749394deda96.htseq.counts,test_version9_GeneExpressionCounts,2e0e3d3b-4ebd-4ebd-9f12-41626fc263de,1266109,2e0e3d3b-4ebd-4ebd-9f12-41626fc263de,2017-10-06T08:22:14.253049-05:00,d5e8cca3d87c9c3c3a05dba6c511bc5a,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,f4fb3dfc-6622-51e0-99d6-950ae3b9c3e6,fe0b727f-3843-5b70-b9c1-8a207b837fc4,TARGET-30-PASWIJ-01A-01R,aliquot
120,TARGET-30-PASWVY,Female,White,Not Hispanic or Latino,2477,Censored,1918.0,Alive,1918.0,2009,2014.0,"ANBL00B1, ANBL0532, ANBL0032",Stage 4,Not Amplified,Hyperdiploid (DI>1),1.15,Unfavorable,Undifferentiated or Poorly Differentiated,Intermediate,"Ganglioneuroblastoma, nodular",C49.4,"Connective, Subcutaneous and other Soft tissues of abdomen Connective, Subcutaneous and other Soft tissues of (see list under C49):  . Abdomen  . abdominal wall  . Umbilicus  Abdominal aorta  Abdominal vena cava  Abdominal wall muscle  Celiac artery  Ilio",High Risk,60,10,60/40,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,76263959-d77a-47d4-aed5-66ded04d0b9e.htseq.counts,test_version33_GeneExpressionCounts,219c79e7-be38-4f9a-a392-8f3697f65877,1276218,219c79e7-be38-4f9a-a392-8f3697f65877,2017-10-06T08:24:05.575877-05:00,dcd5bc503ae499ac06d4d840a721904e,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,0a70b040-959b-54b9-947f-0d9d49ba457f,001c294c-5ae8-55cd-bf07-88112e9b117b,TARGET-30-PASWVY-01A-01R,aliquot
121,TARGET-30-PASWYR,Male,White,Not Hispanic or Latino,958,Censored,1893.0,Alive,1893.0,2009,2014.0,"ANBL00B1, ANBL0032, AEPI07N1",Stage 4,Amplified,Hyperdiploid (DI>1),1.96,Unfavorable,Undifferentiated or Poorly Differentiated,High,Neuroblastoma,C48.0,Retroperitoneum  Periadrenal tissue  Perinephric tissue  Peripancreatic tissue  Perirenal tissue  Retrocecal tissue  Retroperitoneal tissue,High Risk,60,10,60/40,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,02a86e96-346e-4ffa-bada-23b1823416b6.htseq.counts,test_version19_GeneExpressionCounts,e7e1e726-bbd0-4d5d-adb2-3a3cbc0ce36e,1267545,e7e1e726-bbd0-4d5d-adb2-3a3cbc0ce36e,2017-10-06T08:23:00.878915-05:00,8e045badb3da064447e38c566db55a82,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,3f7439bd-7bf7-54ee-bcf8-91182ca29f33,40a927c5-4fed-5df2-84e8-136e869f0f4a,TARGET-30-PASWYR-01A-01R,aliquot
122,TARGET-30-PASXGP,Male,White,Not Hispanic or Latino,834,Censored,1898.0,Alive,1898.0,2009,2014.0,"ANBL00B1, ANBL0532, ANBL0032",Stage 4,Not Amplified,Hyperdiploid (DI>1),1.84,Unfavorable,Undifferentiated or Poorly Differentiated,Low,"Ganglioneuroblastoma, nodular",C74.9,"Adrenal gland, NOS  Suprarenal gland  Adrenal, NOS",High Risk,20,10,20/80,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,3a318128-af26-4e70-a5b5-06ae5be107f3.htseq.counts,test_version74_GeneExpressionCounts,24597e3e-3a92-4302-93e5-57b3821fbee8,1272739,24597e3e-3a92-4302-93e5-57b3821fbee8,2017-10-06T08:27:10.511052-05:00,3332c33923b3d3fa7deec026dc7ba799,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,55881892-03ef-5684-872c-a2a98c5c0b0f,1746a7d8-caf8-598a-9dcc-7c66ce7990b0,TARGET-30-PASXGP-01A-01R,aliquot
123,TARGET-30-PASXHE,Male,Black or African American,Not Hispanic or Latino,1438,Censored,2098.0,Alive,2098.0,2009,2015.0,"ANBL00B1, ANBL0532, ANBL0931, AEPI07N1",Stage 4,Not Amplified,Diploid (DI=1),1.0,Unfavorable,Undifferentiated or Poorly Differentiated,Intermediate,Neuroblastoma,C76.1,"Thorax, NOS  Axilla, NOS  Chest, NOS  Chest wall, NOS  Intrathoracic site, NOS  Thoracic wall, NOS  Infraclavicular region, NOS  Scapular region, NOS",High Risk,80,10,80/20,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,25f23554-b21d-4967-8b7b-040a200b5651.htseq.counts,test_version127_GeneExpressionCounts,2c05f88c-4c27-48aa-b03b-58a50b081c8c,1276778,2c05f88c-4c27-48aa-b03b-58a50b081c8c,2017-10-06T08:31:18.033493-05:00,1baad43a90afbad726593e26ee6ad3b7,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,b60ff20f-8c60-5a22-85fe-db4f2fe32b9a,9fecd8b3-4230-5490-b1eb-7a915fc5a307,TARGET-30-PASXHE-01A-01R,aliquot
124,TARGET-30-PASXIE,Male,White,Not Hispanic or Latino,837,Censored,2123.0,Alive,2123.0,2009,2015.0,"ANBL00B1, ANBL0532, AEPI07N1",Stage 4,Amplified,Diploid (DI=1),1.0,Unfavorable,Undifferentiated or Poorly Differentiated,Intermediate,Neuroblastoma,C48.0,Retroperitoneum  Periadrenal tissue  Perinephric tissue  Peripancreatic tissue  Perirenal tissue  Retrocecal tissue  Retroperitoneal tissue,High Risk,30-40,10,30-40/60-70,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,739f5018-d0d0-4f8c-9a70-f2e2aad9d466.htseq.counts,test_version139_GeneExpressionCounts,b97c966f-472e-4551-9fcd-19b76c1829d6,1262211,b97c966f-472e-4551-9fcd-19b76c1829d6,2017-10-06T08:32:06.875552-05:00,0a56856dcc2ea926f234a5e858adf3c7,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,5906c381-dfae-5b79-ae14-c294ec2fde5b,3892d8ea-a808-59b4-8945-8e0a4288c8ba,TARGET-30-PASXIE-01A-01R,aliquot
125,TARGET-30-PASXRG,Female,White,Unknown,1278,Censored,1749.0,Alive,1749.0,2009,2014.0,"ANBL00B1, ANBL0532, AEPI07N1, ANBL0931",Stage 4,Amplified,Hyperdiploid (DI>1),2.73,Unfavorable,Undifferentiated or Poorly Differentiated,High,"Ganglioneuroblastoma, nodular",C48.0,Retroperitoneum  Periadrenal tissue  Perinephric tissue  Peripancreatic tissue  Perirenal tissue  Retrocecal tissue  Retroperitoneal tissue,High Risk,70-80,10,70-80/20-30,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,1c60f740-95aa-4287-8329-96ec8f871ab2.htseq.counts,test_version5_GeneExpressionCounts,22583de0-d275-48db-926f-fff6f8f7ceb5,1262846,22583de0-d275-48db-926f-fff6f8f7ceb5,2017-10-06T08:22:14.253049-05:00,4f0fa0684af3a650cffe6679ddb6f503,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,b6846ea7-a241-50db-9d16-07d37049ecdc,acffac7c-84e4-5fa1-9eac-a9c42671b6e2,TARGET-30-PASXRG-01A-01R,aliquot
126,TARGET-30-PASXRJ,Female,White,Not Hispanic or Latino,583,Progression,266.0,Alive,1837.0,2009,2014.0,"ANBL00B1, ANBL0532, AEPI07N1",Stage 4,Not Amplified,Diploid (DI=1),1.0,Unfavorable,Undifferentiated or Poorly Differentiated,Low,Neuroblastoma,C76.2,"Abdomen, NOS  Abdominal wall, NOS  Intra-abdominal site, NOS",High Risk,60,10,60/40,,Local + metastatic,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,279b261e-3ec4-44da-8d70-879ce84a79ab.htseq.counts,test_version49_GeneExpressionCounts,441dbe16-af52-4b0a-8d1c-cdcc9eda080d,1275230,441dbe16-af52-4b0a-8d1c-cdcc9eda080d,2017-10-06T08:25:15.152144-05:00,98abe6b1235e72625b2a23650ad9879f,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,4b3e7f04-a5e3-52d3-bbba-da6e8bec0494,66b71469-5569-5811-b712-4c350573532a,TARGET-30-PASXRJ-01A-01R,aliquot
127,TARGET-30-PASZKE,Male,White,Not Hispanic or Latino,31,Death,8.0,Dead,8.0,2009,2009.0,"ANBL00B1, AEPI07N1",Stage 4s,Not Amplified,Hyperdiploid (DI>1),1.38,Unknown,Undifferentiated or Poorly Differentiated,High,Neuroblastoma,C74.9," Adrenal gland, NOS

Suprarenal gland

Adrenal, NOS",Intermediate Risk,85,,,,,,,,hyperdiploid miscoded as diploid/hypodiploid in previous update,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,81988869-de07-4b87-ba00-247b93f58732.htseq.counts,test_version23_GeneExpressionCounts,f8b875ad-91f9-4e9f-a358-7ef08bc92c09,1274643,f8b875ad-91f9-4e9f-a358-7ef08bc92c09,2017-10-06T08:23:20.625172-05:00,484516173f68a0f001705275b2abbeb0,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,cf6d73d0-6e29-5a8c-8258-d50339e6a4fd,8476a0ba-f3a9-5fce-a0a9-f92be14d77fe,TARGET-30-PASZKE-01A-01R,aliquot
128,TARGET-30-PASZPI,Male,White,Not Hispanic or Latino,645,Progression,453.0,Dead,1014.0,2009,2012.0,"ANBL00B1, ANBL0532, ANBL0032",Stage 4,Amplified,Hyperdiploid (DI>1),1.95,Unfavorable,Undifferentiated or Poorly Differentiated,High,Neuroblastoma,C74.9,"Adrenal gland, NOS  Suprarenal gland  Adrenal, NOS",High Risk,40,15,40/60,,Lymph Nodes enlarging node in patients neck (originally thought to be infectious) was MIBG avid on 12/28/2010. Biopsy on 1/25/2011 confirmed NBL at lymph node site.,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,3f7b7f18-4219-40d6-b721-d73aa934f6f7.htseq.counts,test_version45_GeneExpressionCounts,89cf8fe3-fc5c-43d3-b956-856aa62d5a38,1272329,89cf8fe3-fc5c-43d3-b956-856aa62d5a38,2017-10-06T08:25:15.152144-05:00,fa6b100463f10ed5fa6eb71265d71c8d,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,0de3b0b5-21a8-54d6-9d31-870d07b820f4,8c573a88-f886-5fea-a377-541572caefc3,TARGET-30-PASZPI-01A-01R,aliquot
129,TARGET-30-PATAYJ,Male,White,Not Hispanic or Latino,52,Censored,1744.0,Alive,1744.0,2009,2014.0,ANBL00B1,Stage 4s,Not Amplified,Hyperdiploid (DI>1),1.62,Favorable,Undifferentiated or Poorly Differentiated,Low,Neuroblastoma,C38.2, Posterior mediastinum,Low Risk,90,,,,,,,,hyperdiploid miscoded as diploid/hypodiploid in previous update,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,bbb067bf-d4ae-46be-8bea-3f71d371b7f8.htseq.counts,test_version122_GeneExpressionCounts,d513d991-4b52-4f84-af7c-dc2ad7fcd39f,1274791,d513d991-4b52-4f84-af7c-dc2ad7fcd39f,2017-10-06T08:30:54.984868-05:00,ebc2e19582cea95b51446db9941a1e31,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,6280ef5f-8828-555b-9d7e-1b43b3b7dd1a,a5dbfe2f-1905-57fe-9589-2b84cb048f67,TARGET-30-PATAYJ-01A-01R,aliquot
130,TARGET-30-PATBMM,Male,White,Not Hispanic or Latino,1112,Relapse,709.0,Alive,768.0,2009,2011.0,"ANBL00B1, ANBL0032, AEPI07N1, ADVL0912",Stage 4,Not Amplified,Hyperdiploid (DI>1),1.97,Unfavorable,Undifferentiated or Poorly Differentiated,Low,"Ganglioneuroblastoma, nodular",C74.9,"Adrenal gland, NOS  Suprarenal gland  Adrenal, NOS",High Risk,90,10,90/10,,Bone,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,640a9338-f476-4c71-a6a0-52d8f618f6dc.htseq.counts,test_version73_GeneExpressionCounts,56d0bcdf-03a7-4927-ab0b-e6557bdaefe7,1272439,56d0bcdf-03a7-4927-ab0b-e6557bdaefe7,2017-10-06T08:27:10.511052-05:00,c4548a5e345ba40c690b4967a7f5c3c8,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,ed6e594c-d1f0-5563-8362-068c897f8dfe,73ae219d-3c82-52cd-ac97-0556a7cc5baf,TARGET-30-PATBMM-01A-01R,aliquot
131,TARGET-30-PATCFL,Male,White,Not Hispanic or Latino,1041,Censored,2125.0,Alive,2125.0,2009,2015.0,"ANBL00B1, ANBL0032, AEPI07N1",Stage 4,Not Amplified,Diploid (DI=1),1.0,Unfavorable,Undifferentiated or Poorly Differentiated,Intermediate,Neuroblastoma,C76.2,"Abdomen, NOS  Abdominal wall, NOS  Intra-abdominal site, NOS",High Risk,20-30,10,20-30/80-70,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,7cee37af-64ff-4983-bfbf-cb4f95d2b796.htseq.counts,test_version3_GeneExpressionCounts,a0a40207-1f02-4f1c-aa30-b39f97c91d55,1264404,a0a40207-1f02-4f1c-aa30-b39f97c91d55,2017-10-06T08:21:49.750654-05:00,00bfc26b18a2a49b3c8d7a0ac90022b6,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,70c0e0f4-dec7-5d6c-bcc0-078cf51a03ee,b55268a0-0eb4-5c72-b4b7-d34dae3cbb9d,TARGET-30-PATCFL-01A-01R,aliquot
132,TARGET-30-PATDWN,Male,Not Reported,Hispanic or Latino,1435,Censored,278.0,Alive,278.0,2009,2010.0,"ANBL00B1, ANBL0032",Stage 4,Amplified,Diploid (DI=1),1.0,Unfavorable,Undifferentiated or Poorly Differentiated,High,Neuroblastoma,C74.9,"Adrenal gland, NOS  Suprarenal gland  Adrenal, NOS",High Risk,70,10,70/30,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,6d783035-7375-4d76-8f27-415a1e42d37e.htseq.counts,test_version110_GeneExpressionCounts,ae19ed2b-5f5f-4656-877d-915209fb3edf,1272139,ae19ed2b-5f5f-4656-877d-915209fb3edf,2017-10-06T08:30:12.040966-05:00,729cab170ca00d9d81279db191303227,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,38c0ad36-0188-5650-98b7-0eff17ae03a0,cd2c26ff-9c1e-5658-b7f3-2e45935985cc,TARGET-30-PATDWN-01A-01R,aliquot
133,TARGET-30-PATDXC,Male,White,Not Hispanic or Latino,1659,Event,444.0,Dead,916.0,2009,2012.0,"ANBL00B1, ANBL0931",Stage 4,Not Amplified,Hyperdiploid (DI>1),1.17,Unfavorable,Undifferentiated or Poorly Differentiated,High,Neuroblastoma,C48.0,Retroperitoneum  Periadrenal tissue  Perinephric tissue  Peripancreatic tissue  Perirenal tissue  Retrocecal tissue  Retroperitoneal tissue,High Risk,80,10,80/20,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,5f27bcfe-5da2-4d45-ae08-1dd7612610e9.htseq.counts,test_version1_GeneExpressionCounts,14a23ade-233d-4d17-9511-ce86c412144d,1265433,14a23ade-233d-4d17-9511-ce86c412144d,2017-10-06T08:21:49.750654-05:00,92a282afbc6d0527ac97732c69024e99,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,87524953-dfbb-57ae-a29d-d9da436ba770,a952625b-ee78-5a7d-87ba-68b725b3200c,TARGET-30-PATDXC-01A-01R,aliquot
134,TARGET-30-PATDXG,Male,White,Not Hispanic or Latino,688,Censored,2052.0,Alive,2052.0,2009,2015.0,"ANBL00B1, ANBL0032",Stage 4,Amplified,Hyperdiploid (DI>1),1.27,Unfavorable,Undifferentiated or Poorly Differentiated,High,Neuroblastoma,C76.2,"Abdomen, NOS  Abdominal wall, NOS  Intra-abdominal site, NOS",High Risk,90,10,90/10,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,2f2ca307-4a07-4dfe-9c97-d07fc84b5e37.htseq.counts,test_version63_GeneExpressionCounts,c24ae1da-789e-4fd0-b004-ed85d8c39d65,1271199,c24ae1da-789e-4fd0-b004-ed85d8c39d65,2017-10-06T08:26:21.324309-05:00,29f817e443849c15749d040408a49395,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,dc12713d-f4c7-5aca-a049-d6a9a58bdb4d,150c0a51-7f01-50a8-bb5a-86e4e74b77c0,TARGET-30-PATDXG-01A-01R,aliquot
135,TARGET-30-PATEKG,Female,Black or African American,Not Hispanic or Latino,1275,Censored,1988.0,Alive,1988.0,2009,2015.0,"ANBL00B1, ANBL0032",Stage 4,Not Amplified,Diploid (DI=1),1.0,Unfavorable,Undifferentiated or Poorly Differentiated,Intermediate,"Ganglioneuroblastoma, nodular",C74.9,"Adrenal gland, NOS  Suprarenal gland  Adrenal, NOS",High Risk,90,10,90/10,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,773e8883-2d4c-4bbf-8176-f8acdfeb3368.htseq.counts,test_version82_GeneExpressionCounts,bfebe117-1fa5-40e9-9b4b-288300898a3b,1270456,bfebe117-1fa5-40e9-9b4b-288300898a3b,2017-10-06T08:27:57.735394-05:00,412e6ebcb4cc8f1bed56fc5db4cf4fe6,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,1358a6e1-0f20-54fb-a2df-36da978ab1f5,674fb8a1-f3a4-53a7-947a-cca9bdaff65b,TARGET-30-PATEKG-01A-01R,aliquot
136,TARGET-30-PATEPF,Male,White,Hispanic or Latino,1434,Death,304.0,Dead,304.0,2010,2010.0,ANBL00B1,Stage 4,Not Amplified,Diploid (DI=1),1.0,Unfavorable,Undifferentiated or Poorly Differentiated,High,"Ganglioneuroblastoma, nodular",C74.9,"Adrenal gland, NOS  Suprarenal gland  Adrenal, NOS",High Risk,90,30,90/10,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,e4220b7a-96e1-468b-9911-b1bf54ca0c09.htseq.counts,test_version112_GeneExpressionCounts,7aa6b6fb-a28b-4d16-ac90-84c2c6c0dff1,1273636,7aa6b6fb-a28b-4d16-ac90-84c2c6c0dff1,2017-10-06T08:30:12.040966-05:00,ea8a03bc10dea570f97d51dab90bbb0f,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,5cf3e61d-ad83-58c6-bcf2-acf93a56c715,a48a3b28-89ab-57ee-9c43-75f910023267,TARGET-30-PATEPF-01A-01R,aliquot
137,TARGET-30-PATESI,Male,Black or African American,Not Hispanic or Latino,752,Relapse,622.0,Dead,958.0,2010,2012.0,ANBL00B1,Stage 4,Amplified,Diploid (DI=1),1.0,Unfavorable,Undifferentiated or Poorly Differentiated,High,Neuroblastoma,C74.9,"Adrenal gland, NOS  Suprarenal gland  Adrenal, NOS",High Risk,75,25,75/25,,Other metastatic sites,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,1a20922e-1093-4cbc-b466-a89c2f0e8487.htseq.counts,test_version91_GeneExpressionCounts,07488bb4-14b1-4433-9cca-4cfc37b16030,1270033,07488bb4-14b1-4433-9cca-4cfc37b16030,2017-10-06T08:28:39.214953-05:00,92d6270413a0b12767e417edac0b2760,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,411ce033-4f49-52df-8eac-8feb8e157207,6cf510b6-e8da-587a-bb2a-69a4877e1e49,TARGET-30-PATESI-01A-01R,aliquot
138,TARGET-30-PATFCY,Male,White,Not Hispanic or Latino,1040,Death,787.0,Dead,787.0,2010,2012.0,"ANBL00B1, AEPI07N1",Stage 4,Not Amplified,Hyperdiploid (DI>1),1.5,Unfavorable,Undifferentiated or Poorly Differentiated,High,Neuroblastoma,C74.9,"Adrenal gland, NOS  Suprarenal gland  Adrenal, NOS",High Risk,90,10,90/10,,,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,afa10943-b0b6-49f9-8706-6ee5da9c6454.htseq.counts,test_version115_GeneExpressionCounts,eb2d1d01-590d-452c-b421-5df874762121,1273996,eb2d1d01-590d-452c-b421-5df874762121,2017-10-06T08:30:35.588194-05:00,8328b9f69caa634489eb55035fff2451,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,8ad1e331-4a06-5199-9439-244b45b51cb1,0358a998-2b55-5468-abc9-8b26a571e702,TARGET-30-PATFCY-01A-01R,aliquot
139,TARGET-30-PATFXV,Female,White,Hispanic or Latino,648,Progression,236.0,Dead,296.0,2010,2010.0,"ANBL00B1, AEPI07N1",Stage 4,Amplified,Diploid (DI=1),1.0,Unfavorable,Undifferentiated or Poorly Differentiated,High,Neuroblastoma,C76.2,"Abdomen, NOS  Abdominal wall, NOS  Intra-abdominal site, NOS",High Risk,70,10,70/30,,Primary site; Bone; Other metastatic sites,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,7e182ed6-c8aa-4185-a6f5-d351a98b7608.htseq.counts,test_version34_GeneExpressionCounts,f07c4b11-c455-458a-a390-f14be4f805a4,1267553,f07c4b11-c455-458a-a390-f14be4f805a4,2017-10-06T08:24:05.575877-05:00,710bef77e41fe5036f0ffe1ed7746b90,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,a6d5f674-905f-52a2-a443-c6e06b6d5a78,63fa6cd8-e0aa-5bab-ad74-05ff3a780045,TARGET-30-PATFXV-01A-01R,aliquot
140,TARGET-30-PATGJU,Female,White,Not Hispanic or Latino,59,Censored,1219.0,Alive,1219.0,2010,2013.0,ANBL00B1,Stage 4s,Not Amplified,Hyperdiploid (DI>1),1.25,Favorable,Undifferentiated or Poorly Differentiated,Low,Neuroblastoma,C76.2," Abdomen, NOS

Abdominal wall, NOS

Intra-abdominal site, NOS",Low Risk,40,,,,,,,,hyperdiploid miscoded as diploid/hypodiploid in previous update,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,8e24367d-a474-4be9-be51-b951ba1af051.htseq.counts,test_version79_GeneExpressionCounts,34a7817d-afd1-4073-8173-ff86a284f6c9,1276026,34a7817d-afd1-4073-8173-ff86a284f6c9,2017-10-06T08:27:34.954478-05:00,b634cebcc59a0d8385b5063740352de1,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,559d61f2-18d0-5653-bc35-ddc6095fe1b9,01329098-5446-586a-9088-0988d50675e0,TARGET-30-PATGJU-01A-01R,aliquot
141,TARGET-30-PATGLU,Male,White,Not Hispanic or Latino,1037,Relapse,715.0,Dead,1330.0,2010,2013.0,"ANBL00B1, ANBL0931, AEPI07N1",Stage 4,Not Amplified,Diploid (DI=1),1.0,Unfavorable,Undifferentiated or Poorly Differentiated,Intermediate,Neuroblastoma,C74.9,"Adrenal gland, NOS  Suprarenal gland  Adrenal, NOS",High Risk,80,40,80/20,,"Other, specify: Right thoracic soft tissue mass approximately at T4 pedicle.",,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,0d52a6e5-73cd-4853-b781-0c7c02fece21.htseq.counts,test_version81_GeneExpressionCounts,8425d840-4962-41cb-9351-cefbd0566de7,1272414,8425d840-4962-41cb-9351-cefbd0566de7,2017-10-06T08:27:57.735394-05:00,1ee5d689dff582e53a0b327ee3252ac0,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,ec9dcbd4-0231-5c2b-87fd-dc2b376aaa4d,5d2ab973-7270-51eb-b229-2814f186445f,TARGET-30-PATGLU-01A-01R,aliquot
142,TARGET-30-PATHKB,Male,White,Not Hispanic or Latino,7,Censored,1998.0,Alive,1998.0,2010,2015.0,"ANBL00B1, ANBL0531",Stage 4s,Not Amplified,Hyperdiploid (DI>1),1.6,Favorable,Undifferentiated or Poorly Differentiated,Low,Neuroblastoma,C74.9," Adrenal gland, NOS

Suprarenal gland

Adrenal, NOS",Intermediate Risk,80,,,,,,,,hyperdiploid miscoded as diploid/hypodiploid in previous update,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,2145ebc8-5ed7-4a70-bf17-0198874e2ffe.htseq.counts,test_version78_GeneExpressionCounts,88465767-638d-436f-b706-919646852f0a,1272854,88465767-638d-436f-b706-919646852f0a,2017-10-06T08:27:34.954478-05:00,97836e9484d90717dabfeb9274769956,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,4aeef390-9125-56d1-b1e8-c87a54bdd934,fba62f88-d514-5edb-a1fb-0e05fe967191,TARGET-30-PATHKB-01A-01R,aliquot
143,TARGET-30-PATHVK,Female,White,Not Hispanic or Latino,2109,Progression,171.0,Alive,1807.0,2010,2015.0,ANBL00B1,Stage 4,Not Amplified,Hyperdiploid (DI>1),1.29,Unfavorable,Undifferentiated or Poorly Differentiated,High,Neuroblastoma,C74.9,"Adrenal gland, NOS  Suprarenal gland  Adrenal, NOS",High Risk,90,50,90/10,,Bone Marrow,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,aeb9f3e0-28f9-4126-b276-0f787d19ef36.htseq.counts,test_version118_GeneExpressionCounts,22280281-1e0d-459e-9690-0194836e7ebd,1274594,22280281-1e0d-459e-9690-0194836e7ebd,2017-10-06T08:30:35.588194-05:00,7a92189956416ff80921c401cbe89f24,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,03f48068-41ca-5c45-928a-553c585d14e9,c0371fe4-ecc2-5a94-8928-e5b97986100a,TARGET-30-PATHVK-01A-01R,aliquot
144,TARGET-30-PATINJ,Male,White,Not Hispanic or Latino,1037,Relapse,736.0,Dead,822.0,2010,2012.0,"ANBL00B1, AEPI07N1, ANBL0032",Stage 4,Not Amplified,Diploid (DI=1),1.0,Unfavorable,Undifferentiated or Poorly Differentiated,Intermediate,Neuroblastoma,C76.2,"Abdomen, NOS  Abdominal wall, NOS  Intra-abdominal site, NOS",High Risk,75,10,75/25,,Bone; Bone Marrow; Lymph Nodes,,,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,8f97235c-f3b2-4757-b3c8-24701e5348c7.htseq.counts,test_version157_GeneExpressionCounts,53fa7d62-cc67-4952-8b88-6263556bdcbc,1273339,53fa7d62-cc67-4952-8b88-6263556bdcbc,2017-10-06T08:33:38.856860-05:00,53aa2312538bba301c3ffd53ed5aba95,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,52c3cef8-39b6-5e47-991f-74847b5677dd,f1ff87b1-3f1d-50e2-b682-a7645a6b561f,TARGET-30-PATINJ-01A-01R,aliquot
145,TARGET-30-PATNKP,Male,White,Not Hispanic or Latino,3446,Event,616.0,Dead,1549.0,2010,2014.0,"ANBL00B1, ANBL0532, ANBL0931, ADVL0912",Stage 4,Not Amplified,Hyperdiploid (DI>1),1.47,Unfavorable,Undifferentiated or Poorly Differentiated,Intermediate,Neuroblastoma,C48.0," Retroperitoneum

Periadrenal tissue

Perinephric tissue

Per",High Risk,90,,,,,98,1.0,,hyperdiploid miscoded as diploid/hypodiploid in previous update,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,cd0c500a-90eb-4981-85b9-8688cfb7876f.htseq.counts,test_version152_GeneExpressionCounts,6fcc83aa-e12c-42d6-9179-bd4922e2e0de,1268195,6fcc83aa-e12c-42d6-9179-bd4922e2e0de,2017-10-06T08:33:16.304824-05:00,264bc7c478b455eb5f8b490e1320ad2b,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,6dacedcf-2971-5728-87ed-c3c90a28f098,b6d20501-df3f-5d89-a95a-d9871b395983,TARGET-30-PATNKP-02A-01R,aliquot
146,TARGET-30-PATYIL,Female,White,Not Hispanic or Latino,328,Relapse,239.0,Dead,481.0,2011,2012.0,"ANBL00B1, ANBL0531",Stage 4,Not Amplified,Diploid (DI=1),1.0,Favorable,Undifferentiated or Poorly Differentiated,Intermediate,Neuroblastoma,C76.2," Abdomen, NOS

Abdominal wall, NOS

Intra-abdominal site, NOS",Intermediate Risk,70,20-30,70/30,,Primary site; Bone,80,5.0,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,f9ea6862-a705-4bd5-af11-16a683364b25.htseq.counts,test_version27_GeneExpressionCounts,d989481d-a0b5-4f7d-ac31-aa37c4471ea3,1263806,d989481d-a0b5-4f7d-ac31-aa37c4471ea3,2017-10-06T08:23:42.670826-05:00,3b319d10ba87b16fc456baab88be74be,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,5e0a4dcc-12d3-528d-a1bd-c04116ff5fc0,50d78d18-d33c-5e43-bf65-72927cf11632,TARGET-30-PATYIL-02A-01R,aliquot
147,TARGET-30-PATYIL,Female,White,Not Hispanic or Latino,328,Relapse,239.0,Dead,481.0,2011,2012.0,"ANBL00B1, ANBL0531",Stage 4,Not Amplified,Diploid (DI=1),1.0,Favorable,Undifferentiated or Poorly Differentiated,Intermediate,Neuroblastoma,C76.2," Abdomen, NOS

Abdominal wall, NOS

Intra-abdominal site, NOS",Intermediate Risk,70,20-30,70/30,,Primary site; Bone,80,5.0,,,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,e99cf13e-9bdf-402d-9ec4-a8bf771543a5.htseq.counts,test_version6_GeneExpressionCounts,dfe14a8f-8c2c-41f5-9591-29a9dbf00db9,1260772,dfe14a8f-8c2c-41f5-9591-29a9dbf00db9,2017-10-06T08:22:14.253049-05:00,099ecf1ff2b6780177388fdb492b9719,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,a3649f8e-83c0-5595-84b5-9295cfdab010,50d78d18-d33c-5e43-bf65-72927cf11632,TARGET-30-PATYIL-01A-01R,aliquot
148,TARGET-30-PAUDDK,Male,Black or African American,Not Hispanic or Latino,361,Event,344.0,Alive,1528.0,2011,2015.0,"ANBL00B1, ANBL0531",Stage 3,Not Amplified,Hyperdiploid (DI>1),1.33,Favorable,Undifferentiated or Poorly Differentiated,Low,Neuroblastoma,C76.3," Pelvis, NOS

Buttock, NOS

Groin, NOS

Ischiorectal fossa

P",Intermediate Risk,70,,,,,90-95,5.0,,hyperdiploid miscoded as diploid/hypodiploid in previous update,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,204a726c-7058-4580-8131-37d078ecb6a3.htseq.counts,test_version15_GeneExpressionCounts,72058c12-0e77-45f8-a4c9-79db1ff4519a,1264844,72058c12-0e77-45f8-a4c9-79db1ff4519a,2017-10-06T08:23:00.878915-05:00,4bcafe9b14d9a99123f369aaa183a3d2,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,f87b482f-a462-5803-8199-7ba91fcc5cd0,13ea9a20-e20c-5231-b796-b4f8bf747247,TARGET-30-PAUDDK-02A-01R,aliquot
149,TARGET-30-PAUDDK,Male,Black or African American,Not Hispanic or Latino,361,Event,344.0,Alive,1528.0,2011,2015.0,"ANBL00B1, ANBL0531",Stage 3,Not Amplified,Hyperdiploid (DI>1),1.33,Favorable,Undifferentiated or Poorly Differentiated,Low,Neuroblastoma,C76.3," Pelvis, NOS

Buttock, NOS

Groin, NOS

Ischiorectal fossa

P",Intermediate Risk,70,,,,,90-95,5.0,,hyperdiploid miscoded as diploid/hypodiploid in previous update,Gene Expression Quantification,2018-11-30T04:41:54.945003+00:00,391324ba-9289-4a11-854d-1602da0094d1.htseq.counts,test_version29_GeneExpressionCounts,29942956-f9f9-42c1-a575-2e93a6f1ac03,1264940,29942956-f9f9-42c1-a575-2e93a6f1ac03,2017-10-06T08:23:42.670826-05:00,d12a13b1b4ffbbf8cd48b5c2a8d1c49d,TXT,open,released,Transcriptome Profiling,gene_expression,RNA-Seq,TARGET-NBL,767d108e-c54c-5275-b71c-aef54424eb35,13ea9a20-e20c-5231-b796-b4f8bf747247,TARGET-30-PAUDDK-01A-01R,aliquot
